{"recordsFiltered":48602,"recordsTotal":48602,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=status&start=12600","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=status&start=12000","results":[{"registry_id":"NCT03071094","publication_url":"https://clinicaltrials.gov/study/NCT03071094","title":"A Phase I/IIa Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)","has_exemption":false,"start_date":"2017-07-27","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"Transgene","sponsor_slug":"transgene","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03265145","publication_url":"https://clinicaltrials.gov/study/NCT03265145","title":"Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO® RESPIMAT® vs. ICS-LABA Plus LAMA in Patients With COPD","has_exemption":false,"start_date":"2017-09-20","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03250442","publication_url":"https://clinicaltrials.gov/study/NCT03250442","title":"A Randomized Controlled Trial Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Lower Extremity Amputations: A Pilot Study","has_exemption":false,"start_date":"2017-11-01","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT03463889","publication_url":"https://clinicaltrials.gov/study/NCT03463889","title":"Gallium-68 Prostate Specific Membrane Antigen (68Ga-PSMA) PET for Imaging of Thyroid Cancer: A Feasibility Study","has_exemption":false,"start_date":"2018-03-19","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02859142","publication_url":"https://clinicaltrials.gov/study/NCT02859142","title":"Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation","has_exemption":false,"start_date":"2018-03-29","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03503318","publication_url":"https://clinicaltrials.gov/study/NCT03503318","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia","has_exemption":false,"start_date":"2018-04-27","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"Teva Branded Pharmaceutical Products, R&D Inc.","sponsor_slug":"teva-branded-pharmaceutical-products-rd-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03594747","publication_url":"https://clinicaltrials.gov/study/NCT03594747","title":"A Phase 3, Multicenter, Randomized Open-Label Study to Compare the Efficacy and Safety of Tislelizumab (BGB A317, Anti-PD1 Antibody) Combined With Paclitaxel Plus Carboplatin or Nab Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Carboplatin Alone as First-Line Treatment for Untreated Advanced Squamous Non-small Cell Lung Cancer","has_exemption":true,"start_date":"2018-07-30","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"BeiGene","sponsor_slug":"beigene","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02845466","publication_url":"https://clinicaltrials.gov/study/NCT02845466","title":"Proof of Concept Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing","has_exemption":false,"start_date":"2018-08-31","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"McMaster University","sponsor_slug":"mcmaster-university","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT03219385","publication_url":"https://clinicaltrials.gov/study/NCT03219385","title":"Directed Ablation of Uterine Fibroids Using a Noninvasive Approach (DIANA)","has_exemption":false,"start_date":"2018-09-30","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"Mirabilis Medica, Inc.","sponsor_slug":"mirabilis-medica-inc","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT03485053","publication_url":"https://clinicaltrials.gov/study/NCT03485053","title":"2 Part, Phase II Study of Intravenous, Single Ascending Dose Administrations of IOP Injection in Patients With Iron Deficient Anemia","has_exemption":false,"start_date":"2018-11-29","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"MegaPro Biomedical Co. Ltd.","sponsor_slug":"megapro-biomedical-co-ltd","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT03586466","publication_url":"https://clinicaltrials.gov/study/NCT03586466","title":"Pilot for Improved Office Based Treatment of Opioid-Dependence","has_exemption":false,"start_date":"2018-12-01","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"MedicaSafe, Inc.","sponsor_slug":"medicasafe-inc","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT03535740","publication_url":"https://clinicaltrials.gov/study/NCT03535740","title":"Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib","has_exemption":false,"start_date":"2019-01-31","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"Ariad Pharmaceuticals","sponsor_slug":"ariad-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03969485","publication_url":"https://clinicaltrials.gov/study/NCT03969485","title":"Non-Randomized, Open-label, Blinded Evaluator Study Characterizing Effectiveness of Hybrid Fractional Laser for the Treatment of Off Face Body Skin Quality","has_exemption":false,"start_date":"2019-04-29","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"Sciton","sponsor_slug":"sciton","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT04047498","publication_url":"https://clinicaltrials.gov/study/NCT04047498","title":"Studying Stepping Control in Parkinson's Disease Using Alternating DBS","has_exemption":false,"start_date":"2019-05-01","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"University of Oxford","sponsor_slug":"university-of-oxford","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT04492176","publication_url":"https://clinicaltrials.gov/study/NCT04492176","title":"A Clinical Clinical Observation of CO2 Fractional Laser in Female Vaginal Repair: A Non-randomized, Open, Inter-group and Self-controlled Trial Before and After Treatment","has_exemption":false,"start_date":"2019-08-01","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"Xijing Hospital","sponsor_slug":"xijing-hospital","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT04308421","publication_url":"https://clinicaltrials.gov/study/NCT04308421","title":"A Prospective, Double-blind, Split-body, Randomized Controlled Trial to Assess the Efficacy of Low Level Laser Therapy for Pigmentary Disorders","has_exemption":false,"start_date":"2020-03-01","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT04358549","publication_url":"https://clinicaltrials.gov/study/NCT04358549","title":"Open Label, Randomized, Controlled Phase 2 Proof-of-Concept Study of the Use of Favipiravir Compared to Standard of Care in Hospitalized Subjects With COVID-19","has_exemption":true,"start_date":"2020-04-17","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"Fujifilm Pharmaceuticals U.S.A., Inc.","sponsor_slug":"fujifilm-pharmaceuticals-usa-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04348500","publication_url":"https://clinicaltrials.gov/study/NCT04348500","title":"A Phase II Trial to Evaluate the Safety and Tolerability of Clazakizumab® (Anti-IL-6 Monoclonal) Compared to Placebo for the Treatment of COVID-19 Infection","has_exemption":false,"start_date":"2020-04-28","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"reported-late","is_pact":false,"days_late":54},{"registry_id":"NCT04370782","publication_url":"https://clinicaltrials.gov/study/NCT04370782","title":"A Randomized Study Evaluating the Safety and Efficacy of Hydroxychloroquine and Zinc in Combination With Either Azithromycin or Doxycycline for the Treatment of COVID-19 in the Outpatient Setting","has_exemption":false,"start_date":"2020-04-28","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"St. Francis Hospital, New York","sponsor_slug":"st-francis-hospital-new-york","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT04374149","publication_url":"https://clinicaltrials.gov/study/NCT04374149","title":"Interventional Study to Evaluate the Efficacy of Therapeutic Plasma Exchange (TPE) Alone or in Combination With Ruxolitinib in COVID-19 Positive Patients With PENN Grade 2, 3, 4 Cytokine Released Syndrome (CRS)","has_exemption":false,"start_date":"2020-04-30","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"Prisma Health-Upstate","sponsor_slug":"prisma-health-upstate","status":"reported-late","is_pact":false,"days_late":50},{"registry_id":"NCT04502472","publication_url":"https://clinicaltrials.gov/study/NCT04502472","title":"Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma Collected From Individuals With Documented Infection and Recovery From COVID-19 (SARS-CoV-2)","has_exemption":false,"start_date":"2020-06-06","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"reported-late","is_pact":false,"days_late":4},{"registry_id":"NCT04538131","publication_url":"https://clinicaltrials.gov/study/NCT04538131","title":"Sensor-Driven Position-Adaptive Spinal Cord Stimulation for Treatment of Gait Disturbance in Parkinson's Disease","has_exemption":false,"start_date":"2020-07-01","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"Ruijin Hospital","sponsor_slug":"ruijin-hospital","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT05040828","publication_url":"https://clinicaltrials.gov/study/NCT05040828","title":"Early Intervention With Leukotriene Receptor Antagonists in Patients With Grass Pollinosis: Effects on Clinical Symptoms and Allergic Inflammation","has_exemption":false,"start_date":"2020-07-01","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"Beijing Tongren Hospital","sponsor_slug":"beijing-tongren-hospital","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT04319978","publication_url":"https://clinicaltrials.gov/study/NCT04319978","title":"The Effect of IM Dexamethasone Administered Pre-operatively Versus Post-operatively on Pain and Edema Following Surgical Extraction of Mesio-angularly Impacted Mandibular 3 rd Molars","has_exemption":false,"start_date":"2020-07-31","completion_date":"2020-09-30","has_results":false,"results_due":true,"sponsor_name":"Dow University of Health Sciences","sponsor_slug":"dow-university-of-health-sciences","status":"overdue","is_pact":false,"days_late":1673},{"registry_id":"NCT04513652","publication_url":"https://clinicaltrials.gov/study/NCT04513652","title":"A Randomized, Double-Masked, Vehicle-Controlled, Parallel Evaluation of the Local Anesthetic Effect of Articaine Sterile Topical Ophthalmic Solution","has_exemption":false,"start_date":"2020-09-03","completion_date":"2020-09-30","has_results":true,"results_due":true,"sponsor_name":"American Genomics, LLC","sponsor_slug":"american-genomics-llc","status":"reported-late","is_pact":false,"days_late":308},{"registry_id":"NCT02052778","publication_url":"https://clinicaltrials.gov/study/NCT02052778","title":"Phase 1/2 Study of TAS-120 in Patients With Advanced Solid Tumors Harboring FGF/FGFR Aberrations","has_exemption":true,"start_date":"2014-07-21","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"Taiho Oncology, Inc.","sponsor_slug":"taiho-oncology-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02440464","publication_url":"https://clinicaltrials.gov/study/NCT02440464","title":"Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib After Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma (BMT CTN 1302)","has_exemption":false,"start_date":"2015-08-31","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"reported-late","is_pact":true,"days_late":32},{"registry_id":"NCT04490590","publication_url":"https://clinicaltrials.gov/study/NCT04490590","title":"A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma","has_exemption":false,"start_date":"2016-10-01","completion_date":"2020-10-01","has_results":false,"results_due":true,"sponsor_name":"Mingzhi Zhang","sponsor_slug":"mingzhi-zhang","status":"overdue","is_pact":true,"days_late":1672},{"registry_id":"NCT02921269","publication_url":"https://clinicaltrials.gov/study/NCT02921269","title":"A Phase 2 Study of Atezolizumab (MPDL3280A) in Combination With Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer","has_exemption":false,"start_date":"2017-03-10","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":false,"days_late":182},{"registry_id":"NCT03196167","publication_url":"https://clinicaltrials.gov/study/NCT03196167","title":"Efficacy and Safety of Sugammadex (2mg/kg) to Shorten Time-to-extubation Among Postoperative ICU Patients Following AVR, CABG Surgery, or AVR/CABG Surgery- a Prospective Randomized Placebo-controlled Trial.","has_exemption":false,"start_date":"2017-05-13","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"reported-late","is_pact":false,"days_late":4},{"registry_id":"NCT03328052","publication_url":"https://clinicaltrials.gov/study/NCT03328052","title":"Randomized Trial Evaluating the Effectiveness of MYnd Analytics Directed Therapy in Depression","has_exemption":false,"start_date":"2017-10-01","completion_date":"2020-10-01","has_results":false,"results_due":true,"sponsor_name":"Cota Inc.","sponsor_slug":"cota-inc","status":"overdue","is_pact":false,"days_late":1672},{"registry_id":"NCT03355326","publication_url":"https://clinicaltrials.gov/study/NCT03355326","title":"Evaluation of Routine Administration of Glycerin Suppositories to Improve Bowel Function in Patients With Uncomplicated Gastroschisis","has_exemption":false,"start_date":"2017-10-01","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03168776","publication_url":"https://clinicaltrials.gov/study/NCT03168776","title":"A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme™ Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients With Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes","has_exemption":false,"start_date":"2017-10-13","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"Sino Medical Sciences Technology Inc.","sponsor_slug":"sino-medical-sciences-technology-inc","status":"reported-late","is_pact":false,"days_late":217},{"registry_id":"NCT03374631","publication_url":"https://clinicaltrials.gov/study/NCT03374631","title":"Stimulating the Social Brain","has_exemption":false,"start_date":"2017-12-01","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"reported-late","is_pact":false,"days_late":173},{"registry_id":"NCT04571112","publication_url":"https://clinicaltrials.gov/study/NCT04571112","title":"Multi-targets, Single-lead GPi+NBM DBS in Parkinson's Disease With Mild Cognitive Impairment","has_exemption":false,"start_date":"2017-12-04","completion_date":"2020-10-01","has_results":false,"results_due":true,"sponsor_name":"University of Toronto","sponsor_slug":"university-of-toronto","status":"overdue","is_pact":false,"days_late":1672},{"registry_id":"NCT03590353","publication_url":"https://clinicaltrials.gov/study/NCT03590353","title":"Comparsion of the Effects of the Histobal Pacing and Double-lumen Pacing on the Function of Left Atrium","has_exemption":false,"start_date":"2018-06-01","completion_date":"2020-10-01","has_results":false,"results_due":true,"sponsor_name":"The Second Hospital of Hebei Medical University","sponsor_slug":"the-second-hospital-of-hebei-medical-university","status":"overdue","is_pact":false,"days_late":1672},{"registry_id":"NCT03454802","publication_url":"https://clinicaltrials.gov/study/NCT03454802","title":"Passive Leg Raising - an Important Diagnostic Manoeuvre and Its Dependency on the Activity of the Autonomous Nervous System in Critically Ill Patients and Healthy Subjects","has_exemption":false,"start_date":"2018-09-01","completion_date":"2020-10-01","has_results":false,"results_due":true,"sponsor_name":"Region MidtJylland Denmark","sponsor_slug":"region-midtjylland-denmark","status":"overdue","is_pact":false,"days_late":1672},{"registry_id":"NCT03963011","publication_url":"https://clinicaltrials.gov/study/NCT03963011","title":"Pilot Randomized Control Trial of Necrotizing Enterocolitis Screening Abdominal Radiograph Versus Bowel Ultrasound Plus Abdominal Radiograph in Premature Neonates","has_exemption":false,"start_date":"2018-12-20","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"Children's Mercy Hospital Kansas City","sponsor_slug":"childrens-mercy-hospital-kansas-city","status":"reported-late","is_pact":false,"days_late":33},{"registry_id":"NCT04042857","publication_url":"https://clinicaltrials.gov/study/NCT04042857","title":"Safety and Efficacy of Next Science Wound Gel in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO): An Open-Label Pilot Study","has_exemption":false,"start_date":"2019-07-26","completion_date":"2020-10-01","has_results":false,"results_due":true,"sponsor_name":"Next Science TM","sponsor_slug":"next-science-tm","status":"reported-late","is_pact":false,"days_late":761},{"registry_id":"NCT03172026","publication_url":"https://clinicaltrials.gov/study/NCT03172026","title":"Maraviroc to Augment Rehabilitation Outcomes After Stroke","has_exemption":false,"start_date":"2019-08-01","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03949244","publication_url":"https://clinicaltrials.gov/study/NCT03949244","title":"Effect of Nailfold Application of Latanoprostene Bunod on Nailfold Capillary Blood Flow","has_exemption":false,"start_date":"2019-08-15","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04231409","publication_url":"https://clinicaltrials.gov/study/NCT04231409","title":"Study to Demonstrate the Value of Fast-Acting Subperception (FAST) Using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain (COMBO Study)","has_exemption":false,"start_date":"2019-11-26","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"reported-late","is_pact":false,"days_late":6},{"registry_id":"NCT04016844","publication_url":"https://clinicaltrials.gov/study/NCT04016844","title":"Transcranial Direct Current Stimulation to Reduce Asymmetric Glucose Uptake in Leg Muscles of Persons With Multiple Sclerosis","has_exemption":false,"start_date":"2019-12-06","completion_date":"2020-10-01","has_results":true,"results_due":true,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"reported-late","is_pact":false,"days_late":262},{"registry_id":"NCT04150757","publication_url":"https://clinicaltrials.gov/study/NCT04150757","title":"The Use of Intranasal (IN) Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the Pediatric Emergency Department","has_exemption":false,"start_date":"2019-12-19","completion_date":"2020-10-01","has_results":false,"results_due":true,"sponsor_name":"Abigail Nixon","sponsor_slug":"abigail-nixon","status":"overdue","is_pact":false,"days_late":1672},{"registry_id":"NCT04262700","publication_url":"https://clinicaltrials.gov/study/NCT04262700","title":"Customer Outcomes & Value Experiencing A New Monitoring Technology","has_exemption":false,"start_date":"2020-02-07","completion_date":"2020-10-01","has_results":false,"results_due":true,"sponsor_name":"LifeScan Scotland Ltd","sponsor_slug":"lifescan-scotland-ltd","status":"overdue","is_pact":false,"days_late":1672},{"registry_id":"NCT02639182","publication_url":"https://clinicaltrials.gov/study/NCT02639182","title":"A Multi-Center, Open Label, Randomized Phase 2 Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2016-05-03","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03517436","publication_url":"https://clinicaltrials.gov/study/NCT03517436","title":"A Prospective, Single-arm, Controlled, Multicenter Study to Establish the Safety and Effectiveness of the CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement","has_exemption":false,"start_date":"2018-09-18","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03781596","publication_url":"https://clinicaltrials.gov/study/NCT03781596","title":"Randomized Controlled Trial Comparing Fluticasone Plus Omeprazole With Fluticasone Alone for Eosinophilic Esophagitis","has_exemption":false,"start_date":"2018-10-02","completion_date":"2020-10-02","has_results":false,"results_due":true,"sponsor_name":"Claire Daniels","sponsor_slug":"claire-daniels","status":"overdue","is_pact":false,"days_late":1671},{"registry_id":"NCT03705273","publication_url":"https://clinicaltrials.gov/study/NCT03705273","title":"Comparison of Dexamethasone Oral Preparations to Assess Palatability and Adverse Effects in Children With Asthma and Croup","has_exemption":false,"start_date":"2018-10-23","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03519711","publication_url":"https://clinicaltrials.gov/study/NCT03519711","title":"A Phase 1/2, Open-Label, Randomized Parallel Arm, Intra-patient Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of CNSA-001(Sepiapterin) in Primary Tetrahydrobiopterin Deficient Patients With Hyperphenylalaninemia","has_exemption":true,"start_date":"2019-01-03","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"PTC Therapeutics","sponsor_slug":"ptc-therapeutics","status":"reported-late","is_pact":false,"days_late":18},{"registry_id":"NCT03835728","publication_url":"https://clinicaltrials.gov/study/NCT03835728","title":"Exploratory Study of Efficacy of Ocrelizumab in Autoimmune Encephalitis","has_exemption":false,"start_date":"2019-01-22","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03597347","publication_url":"https://clinicaltrials.gov/study/NCT03597347","title":"An Open-label, Non-controlled, Multicenter, Pilot Trial, Using Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial (NTM) Infection","has_exemption":false,"start_date":"2019-06-20","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"Savara Inc.","sponsor_slug":"savara-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04084288","publication_url":"https://clinicaltrials.gov/study/NCT04084288","title":"Intraoperative Acupuncture for Low-Dose Opioid Total Knee Replacement: An Observational Prospective Cohort Study","has_exemption":false,"start_date":"2019-08-21","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04204057","publication_url":"https://clinicaltrials.gov/study/NCT04204057","title":"A Phase 2, Open Label Study to Assess the Efficacy and Safety of Tenalisib (RP6530), a Novel PI3K Dual δ/γ Inhibitor, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)","has_exemption":false,"start_date":"2019-11-28","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"Rhizen Pharmaceuticals SA","sponsor_slug":"rhizen-pharmaceuticals-sa","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04247074","publication_url":"https://clinicaltrials.gov/study/NCT04247074","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination","has_exemption":true,"start_date":"2020-02-10","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04307940","publication_url":"https://clinicaltrials.gov/study/NCT04307940","title":"A Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Analgesic Efficacy and Safety of Naproxen Sodium Tablets and Hydrocodone/Acetaminophen Tablets in Postsurgical Dental Pain","has_exemption":false,"start_date":"2020-03-12","completion_date":"2020-10-02","has_results":true,"results_due":true,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00936390","publication_url":"https://clinicaltrials.gov/study/NCT00936390","title":"A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer","has_exemption":false,"start_date":"2009-09-30","completion_date":"2020-10-03","has_results":true,"results_due":true,"sponsor_name":"Radiation Therapy Oncology Group","sponsor_slug":"radiation-therapy-oncology-group","status":"reported-late","is_pact":true,"days_late":302},{"registry_id":"NCT02349971","publication_url":"https://clinicaltrials.gov/study/NCT02349971","title":"Safety and Feasibility of MR-Guided High Intensity Focused Ultrasound (MR-HIFU) Ablation of Osteoid Osteoma in Children","has_exemption":false,"start_date":"2015-01-31","completion_date":"2020-10-03","has_results":false,"results_due":true,"sponsor_name":"Children's National Research Institute","sponsor_slug":"childrens-national-research-institute","status":"overdue","is_pact":true,"days_late":1670},{"registry_id":"NCT03048422","publication_url":"https://clinicaltrials.gov/study/NCT03048422","title":"Phase III Study of the Virologic Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants","has_exemption":false,"start_date":"2018-01-19","completion_date":"2020-10-03","has_results":true,"results_due":true,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"reported-late","is_pact":false,"days_late":1},{"registry_id":"NCT02840097","publication_url":"https://clinicaltrials.gov/study/NCT02840097","title":"Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study","has_exemption":false,"start_date":"2019-03-04","completion_date":"2020-10-03","has_results":true,"results_due":true,"sponsor_name":"Daniel Nishijima, MD, MAS","sponsor_slug":"daniel-nishijima-md-mas","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02345850","publication_url":"https://clinicaltrials.gov/study/NCT02345850","title":"A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301; Progress II)","has_exemption":false,"start_date":"2015-08-31","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"reported-late","is_pact":true,"days_late":1},{"registry_id":"NCT02626299","publication_url":"https://clinicaltrials.gov/study/NCT02626299","title":"Assessment of DHA On Reducing Early Preterm Birth (ADORE Trial)","has_exemption":false,"start_date":"2016-06-08","completion_date":"2020-10-05","has_results":false,"results_due":true,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"reported-late","is_pact":true,"days_late":251},{"registry_id":"NCT03081052","publication_url":"https://clinicaltrials.gov/study/NCT03081052","title":"Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes","has_exemption":false,"start_date":"2017-05-04","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04015219","publication_url":"https://clinicaltrials.gov/study/NCT04015219","title":"A Prospective, Randomized, and Controlled Clinical Study to Evaluate PROKERA® in the Management of Signs and Symptoms Associated With Dry Eye Disease","has_exemption":false,"start_date":"2018-07-18","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"BioTissue Holdings, Inc","sponsor_slug":"biotissue-holdings-inc","status":"reported-late","is_pact":false,"days_late":378},{"registry_id":"NCT03786380","publication_url":"https://clinicaltrials.gov/study/NCT03786380","title":"Open-label Extension Study of Relamorelin for the Treatment of Diabetic Gastroparesis","has_exemption":false,"start_date":"2018-12-20","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03823300","publication_url":"https://clinicaltrials.gov/study/NCT03823300","title":"A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (LUCERNE)","has_exemption":true,"start_date":"2019-03-11","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03927040","publication_url":"https://clinicaltrials.gov/study/NCT03927040","title":"An Open-Label Extension Study Investigating the Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease","has_exemption":false,"start_date":"2019-04-15","completion_date":"2020-10-05","has_results":false,"results_due":true,"sponsor_name":"NeuroEM Therapeutics, Inc.","sponsor_slug":"neuroem-therapeutics-inc","status":"overdue","is_pact":false,"days_late":1668},{"registry_id":"NCT03954834","publication_url":"https://clinicaltrials.gov/study/NCT03954834","title":"A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone","has_exemption":false,"start_date":"2019-06-03","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04001803","publication_url":"https://clinicaltrials.gov/study/NCT04001803","title":"A Qualitative Hybrid III Implementation Study to Identify and Evaluate Strategies for Successful Implementation of the Cabotegravir + Rilpivirine Long-acting Injectable Regimen in the US","has_exemption":false,"start_date":"2019-07-08","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04150068","publication_url":"https://clinicaltrials.gov/study/NCT04150068","title":"A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long-Acting Capsid Inhibitor GS-6207 in Combination With an Optimized Background Regimen in Heavily Treatment Experienced People Living With HIV-1 Infection With Multidrug Resistance","has_exemption":false,"start_date":"2019-11-21","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04268069","publication_url":"https://clinicaltrials.gov/study/NCT04268069","title":"A Phase 2, Multi-center, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy and Safety of PL9643 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye","has_exemption":false,"start_date":"2020-02-14","completion_date":"2020-10-05","has_results":false,"results_due":true,"sponsor_name":"ORA, Inc.","sponsor_slug":"ora-inc","status":"overdue","is_pact":false,"days_late":1668},{"registry_id":"NCT04349098","publication_url":"https://clinicaltrials.gov/study/NCT04349098","title":"A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients With Severe COVID-19 Infection","has_exemption":false,"start_date":"2020-04-17","completion_date":"2020-10-05","has_results":true,"results_due":true,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02135133","publication_url":"https://clinicaltrials.gov/study/NCT02135133","title":"A Phase II Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Leukemia (SLL)","has_exemption":false,"start_date":"2014-06-30","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported-late","is_pact":true,"days_late":1057},{"registry_id":"NCT02250300","publication_url":"https://clinicaltrials.gov/study/NCT02250300","title":"MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation","has_exemption":false,"start_date":"2014-11-19","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Mehdi Hamadani","sponsor_slug":"mehdi-hamadani","status":"reported-late","is_pact":true,"days_late":455},{"registry_id":"NCT03019185","publication_url":"https://clinicaltrials.gov/study/NCT03019185","title":"A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome","has_exemption":true,"start_date":"2017-03-02","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02925000","publication_url":"https://clinicaltrials.gov/study/NCT02925000","title":"A Phase I/IIa, Open Label, Dose-escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy","has_exemption":false,"start_date":"2017-06-19","completion_date":"2020-10-06","has_results":false,"results_due":true,"sponsor_name":"Taiwan Liposome Company","sponsor_slug":"taiwan-liposome-company","status":"reported-late","is_pact":false,"days_late":244},{"registry_id":"NCT03047213","publication_url":"https://clinicaltrials.gov/study/NCT03047213","title":"An Open Label, Multicenter, Single Arm Phase II Study to Evaluate the Activity and Tolerability of the Novel mTOR Inhibitor, MLN0128 (TAK-228), in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract Whose Tumors Harbor a TSC1 and/or a TSC2 Mutation","has_exemption":false,"start_date":"2017-08-24","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":false,"days_late":1181},{"registry_id":"NCT03342911","publication_url":"https://clinicaltrials.gov/study/NCT03342911","title":"Nivolumab Plus Weekly Carboplatin and Paclitaxel as Induction in Resectable Locally Advanced Head and Neck Cancer","has_exemption":false,"start_date":"2017-11-13","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university","status":"reported-late","is_pact":false,"days_late":663},{"registry_id":"NCT03680846","publication_url":"https://clinicaltrials.gov/study/NCT03680846","title":"A Multi-Center, Prospective, Pragmatic, Randomized, Controlled Clinical Trial to Compare HF10 Therapy to Conventional Medical Management in the Treatment of Non-Surgical Refractory Back Pain","has_exemption":false,"start_date":"2018-09-05","completion_date":"2020-10-06","has_results":false,"results_due":true,"sponsor_name":"Nevro Corp","sponsor_slug":"nevro-corp","status":"overdue","is_pact":false,"days_late":1667},{"registry_id":"NCT03862807","publication_url":"https://clinicaltrials.gov/study/NCT03862807","title":"An Open-label Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of Patisiran-LNP in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) With Disease Progression Post-Orthotopic Liver Transplant","has_exemption":false,"start_date":"2019-03-27","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03886493","publication_url":"https://clinicaltrials.gov/study/NCT03886493","title":"Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer","has_exemption":false,"start_date":"2019-08-28","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04120116","publication_url":"https://clinicaltrials.gov/study/NCT04120116","title":"A Phase 2a, Prospective, Randomized, Double-Blind, Placebo-Controlled, Single and Repeat-Dose, Multicenter, Exploratory Efficacy Study of FX-322 Administered by Intratympanic Injection in Adults With Stable Sensorineural Hearing Loss","has_exemption":true,"start_date":"2019-10-04","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Frequency Therapeutics","sponsor_slug":"frequency-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04179734","publication_url":"https://clinicaltrials.gov/study/NCT04179734","title":"Physiological Study to Determine the Role of the Melanocortin-4 Receptor in Brain Activity in Women With Hypoactive Sexual Desire Disorder","has_exemption":false,"start_date":"2019-10-07","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Imperial College Healthcare NHS Trust","sponsor_slug":"imperial-college-healthcare-nhs-trust","status":"reported-late","is_pact":false,"days_late":561},{"registry_id":"NCT04170296","publication_url":"https://clinicaltrials.gov/study/NCT04170296","title":"A Real World, Multicenter, Open-Label, Multiple Dose Study to Assess the Effectiveness of, and Satisfaction With, CCH Treatment of Buttocks or Thigh Cellulite in Adult Females","has_exemption":false,"start_date":"2019-11-01","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Endo Pharmaceuticals","sponsor_slug":"endo-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04016324","publication_url":"https://clinicaltrials.gov/study/NCT04016324","title":"InterStim Basic Evaluation Lead Post Market Clinical Follow-Up Study","has_exemption":false,"start_date":"2019-11-28","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"MedtronicNeuro","sponsor_slug":"medtronicneuro","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04206020","publication_url":"https://clinicaltrials.gov/study/NCT04206020","title":"A Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study of Safety and Efficacy of SkQ1 Ophthalmic Solution in the Environment and the Controlled Adverse Environmental (CAE®) Model for the Treatment of Dry Eye Syndrome","has_exemption":false,"start_date":"2019-12-20","completion_date":"2020-10-06","has_results":true,"results_due":true,"sponsor_name":"Mitotech, SA","sponsor_slug":"mitotech-sa","status":"reported-late","is_pact":false,"days_late":75},{"registry_id":"NCT02334722","publication_url":"https://clinicaltrials.gov/study/NCT02334722","title":"A Shortened Antiepileptic Drug (AED) Course in Surgical Brain Tumor Patients: A Randomized Trial","has_exemption":false,"start_date":"2015-08-05","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03031782","publication_url":"https://clinicaltrials.gov/study/NCT03031782","title":"A Three-part Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Secukinumab Treatment in Juvenile Idiopathic Arthritis Subtypes of Psoriatic and Enthesitis-related Arthritis","has_exemption":true,"start_date":"2017-05-23","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02865460","publication_url":"https://clinicaltrials.gov/study/NCT02865460","title":"A Randomized, Double-blind Placebo-controlled Phase III Trial of Coenzyme Q10 in Gulf War Illness","has_exemption":false,"start_date":"2017-07-24","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported-late","is_pact":false,"days_late":295},{"registry_id":"NCT03409107","publication_url":"https://clinicaltrials.gov/study/NCT03409107","title":"A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo","has_exemption":false,"start_date":"2018-03-05","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03345160","publication_url":"https://clinicaltrials.gov/study/NCT03345160","title":"Open Label Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study","has_exemption":false,"start_date":"2018-04-27","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03561090","publication_url":"https://clinicaltrials.gov/study/NCT03561090","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients With Gastroesophageal Reflux Disease While Receiving Proton Pump Inhibitors","has_exemption":false,"start_date":"2018-06-20","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"Ironwood Pharmaceuticals, Inc.","sponsor_slug":"ironwood-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03996954","publication_url":"https://clinicaltrials.gov/study/NCT03996954","title":"Validation of a Smartphone-based Recorder for Detection of Cardiac Arrhythmias","has_exemption":false,"start_date":"2018-10-08","completion_date":"2020-10-07","has_results":false,"results_due":true,"sponsor_name":"Blackpool Teaching Hospitals NHS Foundation Trust","sponsor_slug":"blackpool-teaching-hospitals-nhs-foundation-trust","status":"overdue","is_pact":false,"days_late":1666},{"registry_id":"NCT03662074","publication_url":"https://clinicaltrials.gov/study/NCT03662074","title":"Phase II Pilot Study of Subsequent Line Gemcitabine and Nivolumab for Advanced SCLC","has_exemption":false,"start_date":"2018-11-07","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03868839","publication_url":"https://clinicaltrials.gov/study/NCT03868839","title":"An Open-label Feasibility Trial of Adjunctive Telmisartan in Patients With Treatment Resistant Schizophrenia","has_exemption":false,"start_date":"2019-02-01","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"Xiaoduo Fan","sponsor_slug":"xiaoduo-fan","status":"reported-late","is_pact":false,"days_late":61},{"registry_id":"NCT03865407","publication_url":"https://clinicaltrials.gov/study/NCT03865407","title":"Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease","has_exemption":false,"start_date":"2019-03-10","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03863080","publication_url":"https://clinicaltrials.gov/study/NCT03863080","title":"A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension of RVT-1401 in Myasthenia Gravis Patients","has_exemption":true,"start_date":"2019-05-21","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04042077","publication_url":"https://clinicaltrials.gov/study/NCT04042077","title":"A Randomized, Observer-blinded, Active-controlled, Phase Illb Study to Compare IV / Oral Delafloxacin Fixed-dose Monotherapy With Best Available Treatments in a Microbiologically Enriched Population With Surgical Site Infections","has_exemption":false,"start_date":"2019-09-25","completion_date":"2020-10-07","has_results":true,"results_due":true,"sponsor_name":"Menarini Group","sponsor_slug":"menarini-group","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04443920","publication_url":"https://clinicaltrials.gov/study/NCT04443920","title":"Comparison of the Effect of Two Common Regimens of Administration of Tranexamic Acid on Hemostasis and Clinical Outcome of Patients Undergoing Total Knee Arthroplasty","has_exemption":false,"start_date":"2019-10-29","completion_date":"2020-10-07","has_results":false,"results_due":true,"sponsor_name":"The Miriam Hospital","sponsor_slug":"the-miriam-hospital","status":"overdue","is_pact":false,"days_late":1666},{"registry_id":"NCT02231879","publication_url":"https://clinicaltrials.gov/study/NCT02231879","title":"A Phase III Double-Blind Randomized Crossover Study of Plerixafor Versus G-CSF in the Treatment of Patients With WHIM Syndrome.","has_exemption":false,"start_date":"2014-10-14","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"reported-late","is_pact":true,"days_late":76},{"registry_id":"NCT02375672","publication_url":"https://clinicaltrials.gov/study/NCT02375672","title":"A Multi-Center, Single Arm, Phase II Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer: HCRN GI14-186","has_exemption":false,"start_date":"2015-05-28","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"Hoosier Cancer Research Network","sponsor_slug":"hoosier-cancer-research-network","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02361944","publication_url":"https://clinicaltrials.gov/study/NCT02361944","title":"Risk of Oxygen During Cardiac Surgery (ROCS) Trial","has_exemption":true,"start_date":"2016-04-05","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt University","sponsor_slug":"vanderbilt-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02706626","publication_url":"https://clinicaltrials.gov/study/NCT02706626","title":"Phase 2 Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors in Refractory ALK Rearranged Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2017-03-09","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"Criterium, Inc.","sponsor_slug":"criterium-inc","status":"reported-late","is_pact":false,"days_late":202},{"registry_id":"NCT02595996","publication_url":"https://clinicaltrials.gov/study/NCT02595996","title":"An Intra-patient Dose Escalation Study of Propranolol in Patients With Lymphedema","has_exemption":false,"start_date":"2017-06-07","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03242343","publication_url":"https://clinicaltrials.gov/study/NCT03242343","title":"A Multi-center Prospective Study to Evaluate the Safety and Effectiveness of the VasQ External Support for Arteriovenous Fistula","has_exemption":false,"start_date":"2017-11-29","completion_date":"2020-10-08","has_results":false,"results_due":true,"sponsor_name":"Laminate Medical Technologies","sponsor_slug":"laminate-medical-technologies","status":"reported-late","is_pact":false,"days_late":1661},{"registry_id":"NCT03632655","publication_url":"https://clinicaltrials.gov/study/NCT03632655","title":"A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches: Transrectal Ultrasound-guided Biopsy Compared With a Transperineal Approach","has_exemption":false,"start_date":"2017-12-23","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03486912","publication_url":"https://clinicaltrials.gov/study/NCT03486912","title":"A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults With Nonalcoholic Steatohepatitis (NASH) and Compensated Liver Cirrhosis","has_exemption":true,"start_date":"2018-06-12","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03764475","publication_url":"https://clinicaltrials.gov/study/NCT03764475","title":"A Phase 2, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.3% in Adult Subjects With Chronic Plaque Psoriasis Who Have Completed Preceding Study ARQ-151-201 Phase 2 Randomized Controlled Trial (Cohort 1) and Non-ARQ-151-201 Subjects (Cohort 2)","has_exemption":true,"start_date":"2018-12-18","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"Arcutis Biotherapeutics, Inc.","sponsor_slug":"arcutis-biotherapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03866993","publication_url":"https://clinicaltrials.gov/study/NCT03866993","title":"A Phase III, Randomized, Double-blinded, Multicenter Study of AK105 Combined With Carboplatin and Paclitaxel vs Placebo Combined With Carboplatin and Paclitaxel as First-line Therapy in Patients With Metastatic Squamous Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2018-12-20","completion_date":"2020-10-08","has_results":false,"results_due":true,"sponsor_name":"Akeso","sponsor_slug":"akeso","status":"reported-late","is_pact":false,"days_late":1241},{"registry_id":"NCT03675308","publication_url":"https://clinicaltrials.gov/study/NCT03675308","title":"A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1)","has_exemption":true,"start_date":"2019-03-25","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05050071","publication_url":"https://clinicaltrials.gov/study/NCT05050071","title":"Comparative Evaluation of Antibacterial Effect of Allium Sativum, Calcium Hydroxide and Their Combination as Intracanal Medicaments in Infected Mature Teeth. A Randomized Control Trial","has_exemption":false,"start_date":"2019-10-08","completion_date":"2020-10-08","has_results":false,"results_due":true,"sponsor_name":"Suez Canal University","sponsor_slug":"suez-canal-university","status":"overdue","is_pact":false,"days_late":1665},{"registry_id":"NCT03987191","publication_url":"https://clinicaltrials.gov/study/NCT03987191","title":"Successful Transition From Insulin Pump to Multiple Daily Injections Using Insulin Degludec in Adults With Type 1 Diabetes","has_exemption":false,"start_date":"2020-01-10","completion_date":"2020-10-08","has_results":true,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00352976","publication_url":"https://clinicaltrials.gov/study/NCT00352976","title":"Total Body Irradiation Dose De-escalation Study in Patients With Fanconi Anemia Undergoing Alternate Donor Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2006-05-18","completion_date":"2020-10-09","has_results":true,"results_due":true,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01951885","publication_url":"https://clinicaltrials.gov/study/NCT01951885","title":"Tacrolimus, Mini-dose Methotrexate and Mycophenolate Mofetil Versus Tacrolimus and Methotrexate for the Prevention of Acute Graft-versus-Host-Disease","has_exemption":false,"start_date":"2014-07-07","completion_date":"2020-10-09","has_results":true,"results_due":true,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"reported-late","is_pact":true,"days_late":339},{"registry_id":"NCT03261986","publication_url":"https://clinicaltrials.gov/study/NCT03261986","title":"A Prospective RSA and Clinical Evaluation of the Trident II Acetabular Cup","has_exemption":false,"start_date":"2017-06-09","completion_date":"2020-10-09","has_results":false,"results_due":true,"sponsor_name":"Midwest Orthopaedics at Rush","sponsor_slug":"midwest-orthopaedics-at-rush","status":"overdue","is_pact":false,"days_late":1664},{"registry_id":"NCT03398824","publication_url":"https://clinicaltrials.gov/study/NCT03398824","title":"Pilot Study of Metformin for Patients With Fanconi Anemia","has_exemption":false,"start_date":"2018-03-29","completion_date":"2020-10-09","has_results":true,"results_due":true,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"reported-late","is_pact":false,"days_late":341},{"registry_id":"NCT03548220","publication_url":"https://clinicaltrials.gov/study/NCT03548220","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Subjects With Pyruvate Kinase Deficiency","has_exemption":false,"start_date":"2018-08-09","completion_date":"2020-10-09","has_results":true,"results_due":true,"sponsor_name":"Agios Pharmaceuticals, Inc.","sponsor_slug":"agios-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03625466","publication_url":"https://clinicaltrials.gov/study/NCT03625466","title":"An Exploratory Phase 2, 2-part, Randomized, Double-blind, Placebo-controlled Study With a Long-term, Open-label Period to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del","has_exemption":false,"start_date":"2018-08-10","completion_date":"2020-10-09","has_results":true,"results_due":true,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03763175","publication_url":"https://clinicaltrials.gov/study/NCT03763175","title":"Evaluation of the Efficacy and Safety of Single, Daily Oral Doses of SYN-010 Compared to Placebo in Adult Patients With Irritable Bowel Syndrome With Constipation (EASE-DO)","has_exemption":false,"start_date":"2018-12-24","completion_date":"2020-10-09","has_results":true,"results_due":true,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04246554","publication_url":"https://clinicaltrials.gov/study/NCT04246554","title":"Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery","has_exemption":false,"start_date":"2019-05-21","completion_date":"2020-10-09","has_results":true,"results_due":true,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"reported-late","is_pact":false,"days_late":9},{"registry_id":"NCT03880565","publication_url":"https://clinicaltrials.gov/study/NCT03880565","title":"Advanced REperfusion STrategies for Refractory Cardiac Arrest (The ARREST Trial)","has_exemption":false,"start_date":"2019-08-09","completion_date":"2020-10-09","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00630253","publication_url":"https://clinicaltrials.gov/study/NCT00630253","title":"A Study of Cyclophosphamide, Fludarabine, and Antithymocyte Globulin Followed by Matched Sibling Donor Hematopoietic Cell Transplantation in Patients With Fanconi Anemia","has_exemption":false,"start_date":"2000-02-17","completion_date":"2020-10-10","has_results":true,"results_due":true,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT00258427","publication_url":"https://clinicaltrials.gov/study/NCT00258427","title":"Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia MT2002-02","has_exemption":false,"start_date":"2002-03-26","completion_date":"2020-10-10","has_results":true,"results_due":true,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04807543","publication_url":"https://clinicaltrials.gov/study/NCT04807543","title":"Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes","has_exemption":false,"start_date":"2018-01-10","completion_date":"2020-10-10","has_results":false,"results_due":true,"sponsor_name":"Ain Shams University","sponsor_slug":"ain-shams-university","status":"overdue","is_pact":false,"days_late":1663},{"registry_id":"NCT03894904","publication_url":"https://clinicaltrials.gov/study/NCT03894904","title":"Double-Blind, Randomized, Controlled Trial, Small Volume Bolus of Papaverine Versus Heparin to Maintain Patency of Peripheral Arterial Catheters in Pediatric Patients Undergoing Surgical Procedures: Pilot Study","has_exemption":false,"start_date":"2019-04-01","completion_date":"2020-10-10","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04086693","publication_url":"https://clinicaltrials.gov/study/NCT04086693","title":"Peripheral Intravenous Catheter Securement With Tissue Adhesive Compared to Conventional Dressing: A Randomized Controlled Trial","has_exemption":false,"start_date":"2019-09-16","completion_date":"2020-10-10","has_results":true,"results_due":true,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04016779","publication_url":"https://clinicaltrials.gov/study/NCT04016779","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)","has_exemption":false,"start_date":"2019-11-20","completion_date":"2020-10-10","has_results":true,"results_due":true,"sponsor_name":"Supernus Pharmaceuticals, Inc.","sponsor_slug":"supernus-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":221},{"registry_id":"NCT01990950","publication_url":"https://clinicaltrials.gov/study/NCT01990950","title":"Evaluation of the Long-term Safety and Performance of the Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Post-Approval Study","has_exemption":false,"start_date":"2014-03-31","completion_date":"2020-10-12","has_results":true,"results_due":true,"sponsor_name":"Cook Research Incorporated","sponsor_slug":"cook-research-incorporated","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03638622","publication_url":"https://clinicaltrials.gov/study/NCT03638622","title":"Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral","has_exemption":false,"start_date":"2017-03-10","completion_date":"2020-10-12","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03713320","publication_url":"https://clinicaltrials.gov/study/NCT03713320","title":"SOLAR: A Phase 2, Randomized, Open-label, Parallel-group, Active Comparator, Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype","has_exemption":false,"start_date":"2019-04-02","completion_date":"2020-10-12","has_results":true,"results_due":true,"sponsor_name":"miRagen Therapeutics, Inc.","sponsor_slug":"miragen-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04342897","publication_url":"https://clinicaltrials.gov/study/NCT04342897","title":"A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19","has_exemption":false,"start_date":"2020-04-20","completion_date":"2020-10-12","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04470466","publication_url":"https://clinicaltrials.gov/study/NCT04470466","title":"Short Pulse and Q-switched ND-YAG Laser With Topical Carbon Versus Fractional CO2 Laser in Treatment of Enlarged Facial Pores: A Split-face Comparative Study","has_exemption":false,"start_date":"2020-07-19","completion_date":"2020-10-12","has_results":false,"results_due":true,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"overdue","is_pact":false,"days_late":1661},{"registry_id":"NCT01345552","publication_url":"https://clinicaltrials.gov/study/NCT01345552","title":"Phase II Study of Stereotactic Radiosurgery for Patients With Oligo-recurrent Disease","has_exemption":false,"start_date":"2011-06-28","completion_date":"2020-10-13","has_results":false,"results_due":true,"sponsor_name":"Steven Burton","sponsor_slug":"steven-burton","status":"overdue","is_pact":true,"days_late":1660},{"registry_id":"NCT02228382","publication_url":"https://clinicaltrials.gov/study/NCT02228382","title":"A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS","has_exemption":false,"start_date":"2014-11-07","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02384434","publication_url":"https://clinicaltrials.gov/study/NCT02384434","title":"Utilization of Low Level Laser Therapy for Radiation Induced Dermatitis in Patients With Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2015-04-27","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Heath Skinner","sponsor_slug":"heath-skinner","status":"reported-late","is_pact":true,"days_late":1181},{"registry_id":"NCT03115801","publication_url":"https://clinicaltrials.gov/study/NCT03115801","title":"A Phase II Randomized Controlled Trial of Programmed Death -1/Programmed Death Ligand-1(PD-1/PDL-1) Axis Blockade Versus PD-1/PDL-1 Axis Blockade Plus Radiotherapy in Metastatic Genitourinary (Renal/Urothelial) Malignancies","has_exemption":false,"start_date":"2016-11-30","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03038620","publication_url":"https://clinicaltrials.gov/study/NCT03038620","title":"Impact of Liraglutide 3.0 on Body Fat Distribution, Visceral Adiposity, and Cardiometabolic Risk Markers In Overweight and Obese Adults at High Risk for Cardiovascular Disease","has_exemption":false,"start_date":"2017-01-31","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03123939","publication_url":"https://clinicaltrials.gov/study/NCT03123939","title":"Phase IIIb Study for Relapsed/Refractory Pediatric/Young Adult Acute Lymphoblastic Leukemia Patients to be Treated With CTL019","has_exemption":false,"start_date":"2017-04-24","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03070392","publication_url":"https://clinicaltrials.gov/study/NCT03070392","title":"A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma","has_exemption":false,"start_date":"2017-10-16","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Immunocore Ltd","sponsor_slug":"immunocore-ltd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03271047","publication_url":"https://clinicaltrials.gov/study/NCT03271047","title":"An Open-label Phase 1b/2 Study of Binimetinib Administered in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation","has_exemption":false,"start_date":"2017-10-18","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03561701","publication_url":"https://clinicaltrials.gov/study/NCT03561701","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis","has_exemption":false,"start_date":"2018-08-23","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Mycovia Pharmaceuticals Inc.","sponsor_slug":"mycovia-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03684642","publication_url":"https://clinicaltrials.gov/study/NCT03684642","title":"A 56-week, Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly Compared to Dulaglutide Once Weekly in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin","has_exemption":false,"start_date":"2018-09-26","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04057118","publication_url":"https://clinicaltrials.gov/study/NCT04057118","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study to Evaluate the Efficacy and Safety of Oral SKI-O-703 in Patients With Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies","has_exemption":false,"start_date":"2019-03-20","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Oscotec Inc.","sponsor_slug":"oscotec-inc","status":"reported-late","is_pact":false,"days_late":854},{"registry_id":"NCT04357782","publication_url":"https://clinicaltrials.gov/study/NCT04357782","title":"Administration of Intravenous Vitamin C in Novel Coronavirus Infection and Decreased Oxygenation (AVoCaDO): A Phase I/II Safety, Tolerability, and Efficacy Clinical Trial","has_exemption":false,"start_date":"2020-04-16","completion_date":"2020-10-13","has_results":true,"results_due":true,"sponsor_name":"Hunter Holmes Mcguire Veteran Affairs Medical Center","sponsor_slug":"hunter-holmes-mcguire-veteran-affairs-medical-center","status":"reported-late","is_pact":false,"days_late":54},{"registry_id":"NCT02066532","publication_url":"https://clinicaltrials.gov/study/NCT02066532","title":"Phase I/II Trial of Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer","has_exemption":false,"start_date":"2014-06-30","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"Dawn L. Hershman","sponsor_slug":"dawn-l-hershman","status":"reported-late","is_pact":true,"days_late":202},{"registry_id":"NCT03123289","publication_url":"https://clinicaltrials.gov/study/NCT03123289","title":"Novel Gallium 68 Citrate in Orthopedic Infections","has_exemption":false,"start_date":"2017-03-06","completion_date":"2020-10-14","has_results":false,"results_due":true,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03510897","publication_url":"https://clinicaltrials.gov/study/NCT03510897","title":"A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for Acute Kidney Injury (AKI) Following Cardiac Surgery","has_exemption":false,"start_date":"2018-06-29","completion_date":"2020-10-14","has_results":false,"results_due":true,"sponsor_name":"Quark Pharmaceuticals","sponsor_slug":"quark-pharmaceuticals","status":"overdue","is_pact":false,"days_late":1659},{"registry_id":"NCT03636126","publication_url":"https://clinicaltrials.gov/study/NCT03636126","title":"Virtual Reality and tACS for Performance Enhancement","has_exemption":false,"start_date":"2019-01-03","completion_date":"2020-10-14","has_results":false,"results_due":true,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"overdue","is_pact":false,"days_late":1659},{"registry_id":"NCT03734588","publication_url":"https://clinicaltrials.gov/study/NCT03734588","title":"Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors","has_exemption":false,"start_date":"2019-01-30","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"Spark Therapeutics, Inc.","sponsor_slug":"spark-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":826},{"registry_id":"NCT03967847","publication_url":"https://clinicaltrials.gov/study/NCT03967847","title":"Oral Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Rotator Cuff Repair","has_exemption":false,"start_date":"2019-02-11","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"reported-late","is_pact":false,"days_late":20},{"registry_id":"NCT03830333","publication_url":"https://clinicaltrials.gov/study/NCT03830333","title":"A Phase 3, Multicenter, Double-blind, Randomized, Active-controlled Clinical Study to Evaluate the Efficacy and Safety of Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem in Chinese Participants With Complicated Intra-abdominal Infection","has_exemption":false,"start_date":"2019-03-20","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03999411","publication_url":"https://clinicaltrials.gov/study/NCT03999411","title":"A Novel Smartphone-based Intervention to Support Smoking Cessation and Adherence to Antiretroviral Therapy Among People Living With HIV: A Pilot Randomized Clinical Trial","has_exemption":false,"start_date":"2019-09-09","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03890367","publication_url":"https://clinicaltrials.gov/study/NCT03890367","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix® or NeisVac-C® in Healthy Toddlers 12 to 23 Months of Age","has_exemption":false,"start_date":"2019-09-12","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04140695","publication_url":"https://clinicaltrials.gov/study/NCT04140695","title":"A Randomized, Double-blind, Placebo-controlled, Efficacy Study of the Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic Dermatitis","has_exemption":false,"start_date":"2019-10-21","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"reported-late","is_pact":false,"days_late":900},{"registry_id":"NCT04210180","publication_url":"https://clinicaltrials.gov/study/NCT04210180","title":"Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction","has_exemption":false,"start_date":"2019-11-19","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"Rose Research Center, LLC","sponsor_slug":"rose-research-center-llc","status":"reported-late","is_pact":false,"days_late":1},{"registry_id":"NCT04336332","publication_url":"https://clinicaltrials.gov/study/NCT04336332","title":"Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19","has_exemption":false,"start_date":"2020-04-01","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"reported-late","is_pact":false,"days_late":365},{"registry_id":"NCT04501640","publication_url":"https://clinicaltrials.gov/study/NCT04501640","title":"A Phase 4 Open-label, Randomized, Single Oral Dose, Two-way Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of Mirabegron in Healthy Chinese Subjects","has_exemption":false,"start_date":"2020-09-21","completion_date":"2020-10-14","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma China, Inc.","sponsor_slug":"astellas-pharma-china-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02797262","publication_url":"https://clinicaltrials.gov/study/NCT02797262","title":"Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System","has_exemption":false,"start_date":"2015-09-30","completion_date":"2020-10-15","has_results":true,"results_due":true,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02642939","publication_url":"https://clinicaltrials.gov/study/NCT02642939","title":"A Phase II Study of Treatment With Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Two or More Previous Chemotherapy Regimens","has_exemption":false,"start_date":"2015-12-31","completion_date":"2020-10-15","has_results":false,"results_due":true,"sponsor_name":"Check, Jerome H., M.D., Ph.D.","sponsor_slug":"check-jerome-h-md-phd","status":"overdue","is_pact":true,"days_late":1658},{"registry_id":"NCT02715375","publication_url":"https://clinicaltrials.gov/study/NCT02715375","title":"A Double Blind, Randomized, Sham Controlled Trial to Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma","has_exemption":true,"start_date":"2016-03-10","completion_date":"2020-10-15","has_results":false,"results_due":true,"sponsor_name":"General Innovations and Goods, Inc.","sponsor_slug":"general-innovations-and-goods-inc","status":"overdue","is_pact":true,"days_late":928},{"registry_id":"NCT03356145","publication_url":"https://clinicaltrials.gov/study/NCT03356145","title":"12 Versus 20 mL Paracervical Block for Pain-Control During Cervical Preparation for Dilation and Evacuation: A Single-Blinded Randomized Controlled Trial","has_exemption":false,"start_date":"2017-01-01","completion_date":"2020-10-15","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03459846","publication_url":"https://clinicaltrials.gov/study/NCT03459846","title":"A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Platinum-Ineligible Patients With Unresectable Stage IV Urothelial Cancer","has_exemption":true,"start_date":"2018-03-16","completion_date":"2020-10-15","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03453489","publication_url":"https://clinicaltrials.gov/study/NCT03453489","title":"Monitoring Telotristat Ethyl Inhibition of Tryptophan Hydroxylase (TPH) in Neuroendocrine Tumors Using ?-[11C]Methyl-L-tryptophan (AMT)-PET","has_exemption":false,"start_date":"2018-06-20","completion_date":"2020-10-15","has_results":true,"results_due":true,"sponsor_name":"Barbara Ann Karmanos Cancer Institute","sponsor_slug":"barbara-ann-karmanos-cancer-institute","status":"reported-late","is_pact":false,"days_late":985},{"registry_id":"NCT03610581","publication_url":"https://clinicaltrials.gov/study/NCT03610581","title":"A Randomized, Double-blind, Placebo-controlled, First-in-Human, Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of Monovalent HPV16 and HPV18 Ad26-vectored Vaccine Components and an MVA-vectored HPV16/18 Vaccine Component in Otherwise Healthy Women With HPV16 or 18 Infection of the Cervix","has_exemption":false,"start_date":"2018-09-27","completion_date":"2020-10-15","has_results":true,"results_due":true,"sponsor_name":"Janssen Vaccines & Prevention B.V.","sponsor_slug":"janssen-vaccines-prevention-bv","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03633695","publication_url":"https://clinicaltrials.gov/study/NCT03633695","title":"Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens","has_exemption":false,"start_date":"2018-12-04","completion_date":"2020-10-15","has_results":true,"results_due":true,"sponsor_name":"AcuFocus, Inc.","sponsor_slug":"acufocus-inc","status":"reported-late","is_pact":false,"days_late":310},{"registry_id":"NCT03670043","publication_url":"https://clinicaltrials.gov/study/NCT03670043","title":"Tolerance & Responsiveness Improvement for Metformin (TRIM): Open-label, Parallel-group Randomized Trial, Phase 4","has_exemption":false,"start_date":"2019-03-19","completion_date":"2020-10-15","has_results":false,"results_due":true,"sponsor_name":"West Side Institute for Science and Education","sponsor_slug":"west-side-institute-for-science-and-education","status":"overdue","is_pact":false,"days_late":1658},{"registry_id":"NCT03980938","publication_url":"https://clinicaltrials.gov/study/NCT03980938","title":"A Double-Blind, Placebo-Controlled Two-Period 10-Week Treatment Within-Subject Crossover Study Of Cognitive Effects Of Neflamapimod in Early-Stage Huntington Disease (HD)","has_exemption":false,"start_date":"2019-07-08","completion_date":"2020-10-15","has_results":true,"results_due":true,"sponsor_name":"EIP Pharma Inc","sponsor_slug":"eip-pharma-inc","status":"reported-late","is_pact":false,"days_late":8},{"registry_id":"NCT04237207","publication_url":"https://clinicaltrials.gov/study/NCT04237207","title":"Evaluation of AutoSense OS on a Cochlear Implant Sound Processor Programmed With Target CI Fitting Software in Adult Users of the HiResolution Bionic Ear System","has_exemption":false,"start_date":"2019-12-17","completion_date":"2020-10-15","has_results":true,"results_due":true,"sponsor_name":"Advanced Bionics","sponsor_slug":"advanced-bionics","status":"reported-late","is_pact":false,"days_late":112},{"registry_id":"NCT02717611","publication_url":"https://clinicaltrials.gov/study/NCT02717611","title":"A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy","has_exemption":false,"start_date":"2016-03-08","completion_date":"2020-10-16","has_results":true,"results_due":true,"sponsor_name":"Acerta Pharma BV","sponsor_slug":"acerta-pharma-bv","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03029143","publication_url":"https://clinicaltrials.gov/study/NCT03029143","title":"A Phase 4 Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment Outcomes In Nonresponders With Moderately to Severely Active Ulcerative Colitis (ENTERPRET)","has_exemption":false,"start_date":"2017-03-29","completion_date":"2020-10-16","has_results":true,"results_due":true,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03493282","publication_url":"https://clinicaltrials.gov/study/NCT03493282","title":"A Pilot Synaptic Vesicle Glycoprotein 2A (SV2A) PET Study to Evaluate the Effect of CT1812 Treatment on Synaptic Density in Participants With Mild to Moderate Alzheimer's Disease","has_exemption":false,"start_date":"2018-03-28","completion_date":"2020-10-16","has_results":true,"results_due":true,"sponsor_name":"Cognition Therapeutics","sponsor_slug":"cognition-therapeutics","status":"reported-late","is_pact":false,"days_late":270},{"registry_id":"NCT03682770","publication_url":"https://clinicaltrials.gov/study/NCT03682770","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)","has_exemption":true,"start_date":"2018-10-03","completion_date":"2020-10-16","has_results":true,"results_due":true,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03760081","publication_url":"https://clinicaltrials.gov/study/NCT03760081","title":"A Phase 2, Open-Label, Single-Arm, Multicenter Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors","has_exemption":false,"start_date":"2019-03-19","completion_date":"2020-10-16","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02930122","publication_url":"https://clinicaltrials.gov/study/NCT02930122","title":"A Prospective, Single-Center, Randomized, Triple-Blinded, Placebo-Controlled Study of IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions","has_exemption":false,"start_date":"2019-06-20","completion_date":"2020-10-16","has_results":true,"results_due":true,"sponsor_name":"Cale Jacobs, PhD","sponsor_slug":"cale-jacobs-phd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03984305","publication_url":"https://clinicaltrials.gov/study/NCT03984305","title":"Utilization of Target Ranges to Treat Patients With Parkinson's Disease by Objective Measurement Using the Personal KinetiGraph® (PKG®) Compared to Standard of Care Assessment (TARGET-PD)- A Randomized Controlled Trial","has_exemption":false,"start_date":"2019-10-15","completion_date":"2020-10-16","has_results":true,"results_due":true,"sponsor_name":"Global Kinetics Corporation","sponsor_slug":"global-kinetics-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04528017","publication_url":"https://clinicaltrials.gov/study/NCT04528017","title":"Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 2","has_exemption":false,"start_date":"2020-09-01","completion_date":"2020-10-16","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03916731","publication_url":"https://clinicaltrials.gov/study/NCT03916731","title":"First in Human Evaluation of STARgraft AV for Hemodialysis Access in Comparison to ePTFE Vascular Grafts","has_exemption":true,"start_date":"2019-04-02","completion_date":"2020-10-17","has_results":false,"results_due":true,"sponsor_name":"Healionics Corporation","sponsor_slug":"healionics-corporation","status":"overdue","is_pact":false,"days_late":926},{"registry_id":"NCT06893601","publication_url":"https://clinicaltrials.gov/study/NCT06893601","title":"The Effect of Parasternal Block on Postoperative Pain in Patients Undergoing Coronary Artery Bypass Graft Surgery","has_exemption":false,"start_date":"2020-01-18","completion_date":"2020-10-17","has_results":false,"results_due":true,"sponsor_name":"Aydin Adnan Menderes University","sponsor_slug":"aydin-adnan-menderes-university","status":"overdue","is_pact":false,"days_late":1656},{"registry_id":"NCT04362137","publication_url":"https://clinicaltrials.gov/study/NCT04362137","title":"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)","has_exemption":false,"start_date":"2020-05-02","completion_date":"2020-10-17","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03945071","publication_url":"https://clinicaltrials.gov/study/NCT03945071","title":"The Effect of Punctal Plugs in Reducing Ocular Surface Irritation After Povidone-Iodine Preparation of Intravitreal Injection","has_exemption":false,"start_date":"2019-06-01","completion_date":"2020-10-18","has_results":false,"results_due":true,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"overdue","is_pact":false,"days_late":1655},{"registry_id":"NCT03905863","publication_url":"https://clinicaltrials.gov/study/NCT03905863","title":"A Randomized Controlled Multicentre Trial, Examining the Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers","has_exemption":false,"start_date":"2019-06-04","completion_date":"2020-10-18","has_results":true,"results_due":true,"sponsor_name":"Inotec AMD Limited","sponsor_slug":"inotec-amd-limited","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01434602","publication_url":"https://clinicaltrials.gov/study/NCT01434602","title":"A Phase I-II Trial of Everolimus and Sorafenib in Patients With Recurrent High-Grade Gliomas","has_exemption":false,"start_date":"2012-10-02","completion_date":"2020-10-19","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":1},{"registry_id":"NCT03542877","publication_url":"https://clinicaltrials.gov/study/NCT03542877","title":"An Open-Label, Single-Arm, Two-Stage Phase II Study Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2018-06-01","completion_date":"2020-10-19","has_results":true,"results_due":true,"sponsor_name":"Academic Thoracic Oncology Medical Investigators Consortium","sponsor_slug":"academic-thoracic-oncology-medical-investigators-consortium","status":"reported-late","is_pact":false,"days_late":169},{"registry_id":"NCT03562156","publication_url":"https://clinicaltrials.gov/study/NCT03562156","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis","has_exemption":false,"start_date":"2018-08-16","completion_date":"2020-10-19","has_results":true,"results_due":true,"sponsor_name":"Mycovia Pharmaceuticals Inc.","sponsor_slug":"mycovia-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03622593","publication_url":"https://clinicaltrials.gov/study/NCT03622593","title":"A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Patients With Diabetic Macular Edema (RHINE)","has_exemption":true,"start_date":"2018-10-09","completion_date":"2020-10-19","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04479449","publication_url":"https://clinicaltrials.gov/study/NCT04479449","title":"A Prospective, Randomized, Double-blind Phase 2b Clinical Trial to Investigate the Efficacy and Safety of SP-8203 in Patients With Acute Ischemic Stroke Requiring Recombinant Tissue Plasminogen Activator (rtPA) Standard of Care","has_exemption":false,"start_date":"2019-03-18","completion_date":"2020-10-19","has_results":false,"results_due":true,"sponsor_name":"Shin Poong Pharmaceutical Co. Ltd.","sponsor_slug":"shin-poong-pharmaceutical-co-ltd","status":"overdue","is_pact":false,"days_late":1654},{"registry_id":"NCT03763929","publication_url":"https://clinicaltrials.gov/study/NCT03763929","title":"Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of Efficacy and Safety of Trans Sodium Crocetinate (TSC) Administered Onboard Emergency Vehicles for Treatment of Suspected Stroke: PHAST-TSC","has_exemption":false,"start_date":"2019-08-22","completion_date":"2020-10-19","has_results":true,"results_due":true,"sponsor_name":"Diffusion Pharmaceuticals Inc","sponsor_slug":"diffusion-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04030091","publication_url":"https://clinicaltrials.gov/study/NCT04030091","title":"Pilot Study for Evaluation of the Impact of Pulsatile Insulin Infusion Therapy on Vascular Function in Patients With Type 1 and Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2019-09-06","completion_date":"2020-10-19","has_results":false,"results_due":true,"sponsor_name":"Sciema UG","sponsor_slug":"sciema-ug","status":"overdue","is_pact":false,"days_late":1654},{"registry_id":"NCT00629798","publication_url":"https://clinicaltrials.gov/study/NCT00629798","title":"A Phase II Trial of Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2008-02-12","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01444209","publication_url":"https://clinicaltrials.gov/study/NCT01444209","title":"Interstitial Radioactive Iodine Implants for the Treatment of Pan-invasive Pituitary Macroadenomas","has_exemption":false,"start_date":"2011-09-30","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"reported-late","is_pact":true,"days_late":1},{"registry_id":"NCT02851407","publication_url":"https://clinicaltrials.gov/study/NCT02851407","title":"A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant","has_exemption":false,"start_date":"2016-09-01","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02913612","publication_url":"https://clinicaltrials.gov/study/NCT02913612","title":"Efficacy, Safety, and Pharmacokinetics of Timolol in Infants With Infantile Hemangioma (IH)","has_exemption":true,"start_date":"2017-05-05","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"Kanecia Obie Zimmerman","sponsor_slug":"kanecia-obie-zimmerman","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03419741","publication_url":"https://clinicaltrials.gov/study/NCT03419741","title":"Repetitive Transcranial Magnetic Stimulation For Smoking Cessation In Cancer Patients","has_exemption":false,"start_date":"2017-10-21","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03274661","publication_url":"https://clinicaltrials.gov/study/NCT03274661","title":"Evaluating Immune Checkpoint Inhibition In Solid Tumor Patients With Homologous Recombination Repair Deficiency","has_exemption":false,"start_date":"2017-11-03","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"reported-late","is_pact":false,"days_late":671},{"registry_id":"NCT03369444","publication_url":"https://clinicaltrials.gov/study/NCT03369444","title":"A Phase I/II, Open Label, Multicentre, Ascending Single Dose, Safety Study of a Novel Adeno- Associated Viral Vector (FLT180a) in Patients With Haemophilia B","has_exemption":false,"start_date":"2017-12-05","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"University College, London","sponsor_slug":"university-college-london","status":"reported-late","is_pact":false,"days_late":210},{"registry_id":"NCT03622580","publication_url":"https://clinicaltrials.gov/study/NCT03622580","title":"A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Patients With Diabetic Macular Edema (YOSEMITE)","has_exemption":true,"start_date":"2018-09-05","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03804684","publication_url":"https://clinicaltrials.gov/study/NCT03804684","title":"How Does the visuALL Field Analyzer (vFA) Compare to Standard Automatic Perimetry (SAP) in Patients With Mild and Moderate Chronic Open Angle Glaucoma (COAG) and Subjects Without Eye Problems?","has_exemption":false,"start_date":"2019-01-08","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"Wills Eye","sponsor_slug":"wills-eye","status":"reported-late","is_pact":false,"days_late":82},{"registry_id":"NCT03891381","publication_url":"https://clinicaltrials.gov/study/NCT03891381","title":"Electromyographic Monitoring and Postoperative Recovery","has_exemption":false,"start_date":"2019-03-26","completion_date":"2020-10-20","has_results":false,"results_due":true,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"reported-late","is_pact":false,"days_late":600},{"registry_id":"NCT04213573","publication_url":"https://clinicaltrials.gov/study/NCT04213573","title":"Parental Perception of Silver Diamine Fluoride Staining and Its Efficacy on Caries Arrestment in Comparison to Sodium Fluoride With Casein Phosphopeptide-amorphous Calcium Phosphate","has_exemption":false,"start_date":"2020-01-21","completion_date":"2020-10-20","has_results":false,"results_due":true,"sponsor_name":"University of Baghdad","sponsor_slug":"university-of-baghdad","status":"overdue","is_pact":false,"days_late":1653},{"registry_id":"NCT04317040","publication_url":"https://clinicaltrials.gov/study/NCT04317040","title":"A Randomized, Double-blind, Placebo-controlled, Multi-site, Phase III Study to Evaluate the Safety and Efficacy of CD24Fc in COVID-19 Treatment","has_exemption":false,"start_date":"2020-04-24","completion_date":"2020-10-20","has_results":true,"results_due":true,"sponsor_name":"Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","sponsor_slug":"oncoimmune-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04720794","publication_url":"https://clinicaltrials.gov/study/NCT04720794","title":"A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit As Compared To The Hologic Panther Fusion SARS-CoV-2 RT-PCR Assay","has_exemption":false,"start_date":"2020-09-25","completion_date":"2020-10-20","has_results":false,"results_due":true,"sponsor_name":"Lucira Health Inc","sponsor_slug":"lucira-health-inc","status":"reported-late","is_pact":false,"days_late":33},{"registry_id":"NCT03101254","publication_url":"https://clinicaltrials.gov/study/NCT03101254","title":"A Phase I/II Study of LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma","has_exemption":false,"start_date":"2017-06-06","completion_date":"2020-10-21","has_results":true,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported-late","is_pact":false,"days_late":741},{"registry_id":"NCT03521804","publication_url":"https://clinicaltrials.gov/study/NCT03521804","title":"A Single-Arm Study to Assess the Safety and Efficacy of the SoundBite™ Crossing System With ACTIVE Wire in Coronary Chronic Total Occlusions (the ACTIVE Trial).","has_exemption":false,"start_date":"2018-06-21","completion_date":"2020-10-21","has_results":false,"results_due":true,"sponsor_name":"SoundBite Medical Solutions, Inc.","sponsor_slug":"soundbite-medical-solutions-inc","status":"overdue","is_pact":false,"days_late":1652},{"registry_id":"NCT04293679","publication_url":"https://clinicaltrials.gov/study/NCT04293679","title":"An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)","has_exemption":false,"start_date":"2019-03-21","completion_date":"2020-10-21","has_results":false,"results_due":true,"sponsor_name":"Sirnaomics","sponsor_slug":"sirnaomics","status":"overdue","is_pact":false,"days_late":1652},{"registry_id":"NCT06244290","publication_url":"https://clinicaltrials.gov/study/NCT06244290","title":"Clinical Study to Assess the Efficacy of a Dentifrice Containing Stannous Fluoride as Compared to a Commercially-available Potassium-based Toothpaste and a Regular Fluoride Toothpaste on the Reduction of Dentinal Hypersensitivity.","has_exemption":false,"start_date":"2020-09-28","completion_date":"2020-10-21","has_results":false,"results_due":true,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"overdue","is_pact":false,"days_late":1652},{"registry_id":"NCT02963493","publication_url":"https://clinicaltrials.gov/study/NCT02963493","title":"A Single Arm, Open-Label, Phase 2 Study of Melflufen in Combination With Dexamethasone in Patients With Relapsed Refractory Multiple Myeloma Who Are Refractory to Pomalidomide and/or an Anti-CD38 Monoclonal Antibody","has_exemption":false,"start_date":"2016-12-28","completion_date":"2020-10-22","has_results":true,"results_due":true,"sponsor_name":"Oncopeptides AB","sponsor_slug":"oncopeptides-ab","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03078192","publication_url":"https://clinicaltrials.gov/study/NCT03078192","title":"Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging","has_exemption":false,"start_date":"2017-05-03","completion_date":"2020-10-22","has_results":true,"results_due":true,"sponsor_name":"Bastiaan Driehuys","sponsor_slug":"bastiaan-driehuys","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03533257","publication_url":"https://clinicaltrials.gov/study/NCT03533257","title":"Phase II Study to Assess the Safety, Tolerability, and Target Engagement of AMX0035, a Fixed Combination of Sodium Phenylbutyrate and Tauroursodeoxycholic Acid for the Treatment of Alzheimer's Disease","has_exemption":false,"start_date":"2018-09-14","completion_date":"2020-10-22","has_results":true,"results_due":true,"sponsor_name":"Amylyx Pharmaceuticals Inc.","sponsor_slug":"amylyx-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":1004},{"registry_id":"NCT02188368","publication_url":"https://clinicaltrials.gov/study/NCT02188368","title":"A Phase 2 Study of Pomalidomide as a Replacement for Lenalidomide for Multiple Myeloma Patients Relapsed or Refractory to a Lenalidomide-Containing Combination Regimen","has_exemption":false,"start_date":"2014-07-07","completion_date":"2020-10-23","has_results":false,"results_due":true,"sponsor_name":"Oncotherapeutics","sponsor_slug":"oncotherapeutics","status":"reported-late","is_pact":true,"days_late":1187},{"registry_id":"NCT02569242","publication_url":"https://clinicaltrials.gov/study/NCT02569242","title":"ONO-4538 Phase III Study A Multicenter, Randomized, Open-label Study in Patients With Esophageal Cancer Refractory or Intolerant to Combination Therapy With Fluoropyrimidine and Platinum-based Drugs","has_exemption":false,"start_date":"2015-12-14","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"Ono Pharmaceutical Co. Ltd","sponsor_slug":"ono-pharmaceutical-co-ltd","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02878603","publication_url":"https://clinicaltrials.gov/study/NCT02878603","title":"Prospective Follow-up Study for Patients Who Completed Study ALX0681-C301 (HERCULES) to Evaluate Long-term Safety and Efficacy of Caplacizumab (Post-HERCULES)","has_exemption":false,"start_date":"2016-10-06","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03011307","publication_url":"https://clinicaltrials.gov/study/NCT03011307","title":"Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery","has_exemption":false,"start_date":"2017-01-12","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":true,"days_late":282},{"registry_id":"NCT03437278","publication_url":"https://clinicaltrials.gov/study/NCT03437278","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2b Dose-finding Study to Investigate the Efficacy and Safety of Ligelizumab (QGE031) in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)","has_exemption":false,"start_date":"2018-08-01","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03648827","publication_url":"https://clinicaltrials.gov/study/NCT03648827","title":"Phase 2 Clinical Pharmacology Study to Assess Dystrophin Levels in Subjects With nmDMD Before and After Treatment With Ataluren","has_exemption":true,"start_date":"2018-12-21","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"PTC Therapeutics","sponsor_slug":"ptc-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03463915","publication_url":"https://clinicaltrials.gov/study/NCT03463915","title":"Randomized Controlled Trial Comparing Two Different Bladder Instillation Treatments for Interstitial Cystitis/Bladder Pain Syndrome","has_exemption":false,"start_date":"2019-01-25","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"Olivia Cardenas-Trowers, M.D.","sponsor_slug":"olivia-cardenas-trowers-md","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03805438","publication_url":"https://clinicaltrials.gov/study/NCT03805438","title":"Determining the ED90 for Intrathecal 3% Chloroprocaine for Elective Cervical Cerclage Surgery","has_exemption":false,"start_date":"2019-02-07","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04039022","publication_url":"https://clinicaltrials.gov/study/NCT04039022","title":"An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Major Depressive Disorder","has_exemption":true,"start_date":"2019-07-08","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"Axsome Therapeutics, Inc.","sponsor_slug":"axsome-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04412668","publication_url":"https://clinicaltrials.gov/study/NCT04412668","title":"A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of ATYR1923 In Adult Patients With Severe Pneumonia Related to SARS-CoV-2 Infection (COVID-19)","has_exemption":false,"start_date":"2020-06-04","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"aTyr Pharma, Inc.","sponsor_slug":"atyr-pharma-inc","status":"reported-late","is_pact":false,"days_late":612},{"registry_id":"NCT04626271","publication_url":"https://clinicaltrials.gov/study/NCT04626271","title":"Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands","has_exemption":false,"start_date":"2020-08-31","completion_date":"2020-10-23","has_results":true,"results_due":true,"sponsor_name":"Healthy.io Ltd.","sponsor_slug":"healthyio-ltd","status":"reported-late","is_pact":false,"days_late":310},{"registry_id":"NCT03956225","publication_url":"https://clinicaltrials.gov/study/NCT03956225","title":"Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study","has_exemption":false,"start_date":"2019-06-25","completion_date":"2020-10-24","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03318523","publication_url":"https://clinicaltrials.gov/study/NCT03318523","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Blinded Period, to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects With Parkinson's Disease","has_exemption":false,"start_date":"2018-01-10","completion_date":"2020-10-26","has_results":true,"results_due":true,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03823287","publication_url":"https://clinicaltrials.gov/study/NCT03823287","title":"A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (TENAYA)","has_exemption":true,"start_date":"2019-02-19","completion_date":"2020-10-26","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03917719","publication_url":"https://clinicaltrials.gov/study/NCT03917719","title":"An Open-Label Extension Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy","has_exemption":false,"start_date":"2019-03-14","completion_date":"2020-10-26","has_results":false,"results_due":true,"sponsor_name":"Catabasis Pharmaceuticals","sponsor_slug":"catabasis-pharmaceuticals","status":"overdue","is_pact":false,"days_late":1647},{"registry_id":"NCT03795116","publication_url":"https://clinicaltrials.gov/study/NCT03795116","title":"Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention","has_exemption":false,"start_date":"2019-03-18","completion_date":"2020-10-26","has_results":true,"results_due":true,"sponsor_name":"State University of New York - Downstate Medical Center","sponsor_slug":"state-university-of-new-york-downstate-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04203537","publication_url":"https://clinicaltrials.gov/study/NCT04203537","title":"A Two-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics and Preliminary Efficacy Study of CA-008 in Patients Undergoing Total Knee Arthroplasy","has_exemption":false,"start_date":"2019-12-04","completion_date":"2020-10-26","has_results":true,"results_due":true,"sponsor_name":"Concentric Analgesics","sponsor_slug":"concentric-analgesics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04391036","publication_url":"https://clinicaltrials.gov/study/NCT04391036","title":"A Randomized Double-Blind Cross-Over Study of Self-Insertion of Two Formulations of a Placebo Vaginal Film","has_exemption":false,"start_date":"2020-07-14","completion_date":"2020-10-26","has_results":true,"results_due":true,"sponsor_name":"Katherine Bunge","sponsor_slug":"katherine-bunge","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00774345","publication_url":"https://clinicaltrials.gov/study/NCT00774345","title":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia Following Second-Line Therapy (The Continuum Trial)","has_exemption":false,"start_date":"2009-01-27","completion_date":"2020-10-27","has_results":true,"results_due":true,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03013491","publication_url":"https://clinicaltrials.gov/study/NCT03013491","title":"An Open-Label, Dose-Finding and Proof of Concept Study of the PD-L1 Probody® Therapeutic , CX-072, as Monotherapy and in Combination With Yervoy (Ipilimumab) or With Zelboraf (Vemurafenib) in Subjects With Advanced or Recurrent Solid Tumors or Lymphomas","has_exemption":false,"start_date":"2017-01-19","completion_date":"2020-10-27","has_results":true,"results_due":true,"sponsor_name":"CytomX Therapeutics","sponsor_slug":"cytomx-therapeutics","status":"reported-late","is_pact":false,"days_late":1274},{"registry_id":"NCT03194321","publication_url":"https://clinicaltrials.gov/study/NCT03194321","title":"A Prospective, Pilot Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in HLA Sensitized Kidney Transplant Recipients","has_exemption":false,"start_date":"2017-09-11","completion_date":"2020-10-27","has_results":true,"results_due":true,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03219333","publication_url":"https://clinicaltrials.gov/study/NCT03219333","title":"A Single-arm, Open-label, Multicenter Study of Enfortumab Vedotin (ASG-22CE) for Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Immune Checkpoint Inhibitor (CPI) Therapy","has_exemption":false,"start_date":"2017-10-08","completion_date":"2020-10-27","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma Inc","sponsor_slug":"astellas-pharma-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03444844","publication_url":"https://clinicaltrials.gov/study/NCT03444844","title":"Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer Patients With Intermediate/High Risk Primary Disease or Biochemical Recurrence After Treatment","has_exemption":false,"start_date":"2018-05-10","completion_date":"2020-10-27","has_results":false,"results_due":true,"sponsor_name":"Five Eleven Pharma, Inc.","sponsor_slug":"five-eleven-pharma-inc","status":"reported-late","is_pact":false,"days_late":382},{"registry_id":"NCT03410693","publication_url":"https://clinicaltrials.gov/study/NCT03410693","title":"A Randomized, Open Label, Multicenter Phase 2/3 Study to Evaluate the Efficacy and Safety of Rogaratinib (BAY1163877) Compared to Chemotherapy in Patients With FGFR-positive Locally Advanced or Metastatic Urothelial Carcinoma Who Have Received Prior Platinum-containing Chemotherapy","has_exemption":false,"start_date":"2018-05-31","completion_date":"2020-10-27","has_results":true,"results_due":true,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03390907","publication_url":"https://clinicaltrials.gov/study/NCT03390907","title":"Hybrid APC Assisted EMR for Large Colon Polyps to Reduce Local Recurrence : A Prospective Data Collection Study","has_exemption":false,"start_date":"2018-09-28","completion_date":"2020-10-27","has_results":true,"results_due":true,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03523507","publication_url":"https://clinicaltrials.gov/study/NCT03523507","title":"A Randomized, Sham-controlled, Double-blinded Study of Bilateral Prefrontal Individual Connectome-targeted Repetitive Transcranial Magnetic Stimulation to Treat the Symptoms of Depression Associated With Concussive Traumatic Brain Injury.","has_exemption":false,"start_date":"2019-07-01","completion_date":"2020-10-27","has_results":false,"results_due":true,"sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","sponsor_slug":"henry-m-jackson-foundation-for-the-advancement-of-military-medicine","status":"overdue","is_pact":false,"days_late":1646},{"registry_id":"NCT00477412","publication_url":"https://clinicaltrials.gov/study/NCT00477412","title":"Phase I/II Study of Bortezomib (VELCADE) Plus Rituximab-HyperCVAD Alternating With Bortezomib Plus Rituximab-High Dose Methotrexate/Cytarabine in Patients With Untreated Aggressive Mantle Cell Lymphoma","has_exemption":false,"start_date":"2007-04-03","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01431209","publication_url":"https://clinicaltrials.gov/study/NCT01431209","title":"A Phase 2 Multicenter, Investigator Initiated Study of Oral Ruxolitinib Phosphate for the Treatment of Relapsed or Refractory Diffuse Large B-Cell and Peripheral T-Cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2011-08-12","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01889186","publication_url":"https://clinicaltrials.gov/study/NCT01889186","title":"A Phase 2 Open-Label Study of the Efficacy of ABT-199 (GDC-0199) in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia Harboring the 17p Deletion","has_exemption":false,"start_date":"2013-06-27","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02606461","publication_url":"https://clinicaltrials.gov/study/NCT02606461","title":"A Phase 2-3, Multicenter, Randomized, Double-blind Study of Selinexor (KPT-330) Versus Placebo in Patients With Advanced Unresectable Dedifferentiated Liposarcoma (DDLS)","has_exemption":false,"start_date":"2016-01-04","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"reported-late","is_pact":true,"days_late":11},{"registry_id":"NCT02704403","publication_url":"https://clinicaltrials.gov/study/NCT02704403","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Nonalcoholic Steatohepatitis (NASH) and Fibrosis","has_exemption":false,"start_date":"2016-03-31","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"Genfit","sponsor_slug":"genfit","status":"reported-late","is_pact":true,"days_late":71},{"registry_id":"NCT02971761","publication_url":"https://clinicaltrials.gov/study/NCT02971761","title":"A Phase 2 Clinical Trial of the Combination of Pembrolizumab and Selective Androgen Receptor Modulator (SARM) GTX-024 in Patients With Metastatic Androgen Receptor (AR) Positive Triple Negative Breast Cancer (TNBC)","has_exemption":false,"start_date":"2017-06-01","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03537651","publication_url":"https://clinicaltrials.gov/study/NCT03537651","title":"A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation","has_exemption":false,"start_date":"2018-04-25","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03706040","publication_url":"https://clinicaltrials.gov/study/NCT03706040","title":"A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Risankizumab in Adult and Adolescent Subjects With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2018-12-27","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03866200","publication_url":"https://clinicaltrials.gov/study/NCT03866200","title":"Resveratrol Trial for Relief of Pain in Pseudoachondroplasia","has_exemption":true,"start_date":"2019-06-29","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04133519","publication_url":"https://clinicaltrials.gov/study/NCT04133519","title":"The Efficacy and Safety of IBS Digital Behavioral Treatment Study","has_exemption":true,"start_date":"2019-10-23","completion_date":"2020-10-28","has_results":true,"results_due":true,"sponsor_name":"metaMe Health","sponsor_slug":"metame-health","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02627677","publication_url":"https://clinicaltrials.gov/study/NCT02627677","title":"A Randomized, Open-label Study of Ponatinib Versus Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase Following Resistance to Imatinib","has_exemption":false,"start_date":"2015-12-31","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Ariad Pharmaceuticals","sponsor_slug":"ariad-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03181542","publication_url":"https://clinicaltrials.gov/study/NCT03181542","title":"A Randomized Controlled Study of Efficacy of Infra Red Vein Illumination Versus Standard Technique","has_exemption":false,"start_date":"2017-07-10","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03140670","publication_url":"https://clinicaltrials.gov/study/NCT03140670","title":"A Phase 2, Open Label Study of Rucaparib in Patients With Advanced Pancreatic Cancer and a Known Deleterious Germline or Somatic BRCA or PALB2 Mutation","has_exemption":false,"start_date":"2017-09-05","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"reported-late","is_pact":false,"days_late":536},{"registry_id":"NCT03347110","publication_url":"https://clinicaltrials.gov/study/NCT03347110","title":"A Multicenter, Open-Label, Follow-Up Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis","has_exemption":true,"start_date":"2017-11-22","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03406975","publication_url":"https://clinicaltrials.gov/study/NCT03406975","title":"Multi-center ESG Randomized Interventional Trial (MERIT-Trial)","has_exemption":true,"start_date":"2017-12-20","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03476876","publication_url":"https://clinicaltrials.gov/study/NCT03476876","title":"Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers - A Randomized Clinical Trial","has_exemption":false,"start_date":"2018-04-02","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"reported-late","is_pact":false,"days_late":514},{"registry_id":"NCT03368781","publication_url":"https://clinicaltrials.gov/study/NCT03368781","title":"Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Recurrent Atrial Fibrillation Following a Failed AF Ablation (RECOVER AF)","has_exemption":false,"start_date":"2018-04-12","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Acutus Medical","sponsor_slug":"acutus-medical","status":"reported-late","is_pact":false,"days_late":139},{"registry_id":"NCT04003155","publication_url":"https://clinicaltrials.gov/study/NCT04003155","title":"A Phase 3, Randomized, Placebo-controlled, 12-week Double-blind Study, Followed by a Non-Controlled Extension Treatment Period, to Assess the Efficacy and Safety of Fezolinetant in Women Suffering From Moderate to Severe Vasomotor Symptoms (Hot Flashes) Associated With Menopause","has_exemption":true,"start_date":"2019-07-11","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03943147","publication_url":"https://clinicaltrials.gov/study/NCT03943147","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 With Background Treatment in Subjects With Lupus Nephritis","has_exemption":true,"start_date":"2019-07-15","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04006873","publication_url":"https://clinicaltrials.gov/study/NCT04006873","title":"A Randomised Crossover Pilot Study of the Effects of Tezacaftor/Ivacaftor and Ivacaftor on Gastrointestinal Function Using Magnetic Resonance Imaging Parameters in People With Cystic Fibrosis","has_exemption":false,"start_date":"2019-09-03","completion_date":"2020-10-29","has_results":false,"results_due":true,"sponsor_name":"Nottingham University Hospitals NHS Trust","sponsor_slug":"nottingham-university-hospitals-nhs-trust","status":"overdue","is_pact":false,"days_late":1644},{"registry_id":"NCT04120194","publication_url":"https://clinicaltrials.gov/study/NCT04120194","title":"A Phase 3, Randomized, Observer-blinded, Active-controlled Trial to Evaluate Immunogenicity & Safety of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With Matrix-M1™ Adjuvant Against Fluzone® Quadrivalent in Clinically Stable Adults ≥ 65 Years of Age","has_exemption":false,"start_date":"2019-10-14","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Novavax","sponsor_slug":"novavax","status":"reported-late","is_pact":false,"days_late":297},{"registry_id":"NCT04172831","publication_url":"https://clinicaltrials.gov/study/NCT04172831","title":"A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of TNX-102 SL Taken Daily At Bedtime In Patients With Fibromyalgia","has_exemption":false,"start_date":"2019-12-09","completion_date":"2020-10-29","has_results":true,"results_due":true,"sponsor_name":"Tonix Pharmaceuticals, Inc.","sponsor_slug":"tonix-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":216},{"registry_id":"NCT02547662","publication_url":"https://clinicaltrials.gov/study/NCT02547662","title":"Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients With Multiple Myeloma With Extramedullary Disease or Plasma Cell Leukemia","has_exemption":false,"start_date":"2015-12-24","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported-late","is_pact":true,"days_late":2},{"registry_id":"NCT02790736","publication_url":"https://clinicaltrials.gov/study/NCT02790736","title":"Brief Intervention to Reduce Fear of Public Speaking","has_exemption":false,"start_date":"2016-06-30","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03274024","publication_url":"https://clinicaltrials.gov/study/NCT03274024","title":"The Asia Primary Tube Versus Trab (TVT) Study","has_exemption":false,"start_date":"2016-09-28","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Singapore Eye Research Institute","sponsor_slug":"singapore-eye-research-institute","status":"overdue","is_pact":true,"days_late":1643},{"registry_id":"NCT02970136","publication_url":"https://clinicaltrials.gov/study/NCT02970136","title":"Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention: South Florida Center for Reducing Health Disparities","has_exemption":false,"start_date":"2017-04-11","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03494348","publication_url":"https://clinicaltrials.gov/study/NCT03494348","title":"Aspects of Alignment, Function, and Migration Behaviour in Two Conceptually Different Articular Surface Designs in the Cruciate Retaining Version of the Cemented Persona Knee System - A Randomized Study Evaluated by RSA and CT Analysis","has_exemption":false,"start_date":"2017-10-01","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Region Skane","sponsor_slug":"region-skane","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT03247439","publication_url":"https://clinicaltrials.gov/study/NCT03247439","title":"A Prospective Study to Evaluate the Safety and Effectiveness of the Cartiva® Synthetic Cartilage Implant for CMC in the Treatment of First Carpometacarpal Joint Osteoarthritis as Compared to a Ligament Reconstruction Tendon Interposition (LRTI) Comparator","has_exemption":false,"start_date":"2017-12-22","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Cartiva, Inc.","sponsor_slug":"cartiva-inc","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT03420781","publication_url":"https://clinicaltrials.gov/study/NCT03420781","title":"A 46-week, Double-blind, Placebo-controlled, Phase 3 Study With a 6-week Randomized-withdrawal Period to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis","has_exemption":false,"start_date":"2018-01-24","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02402374","publication_url":"https://clinicaltrials.gov/study/NCT02402374","title":"Randomized, Placebo-controlled, Blind-assessor Study to Evaluate the Safety and Efficacy of Autologous Platelet Rich Plasma Gel Prepared With the RegenKit-BCT Plus Family of Kits for the Treatment of Diabetic Foot Ulcer","has_exemption":false,"start_date":"2018-04-12","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Regen Lab SA","sponsor_slug":"regen-lab-sa","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT03486834","publication_url":"https://clinicaltrials.gov/study/NCT03486834","title":"Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3-Dose Regimen of V160 (Cytomegalovirus [CMV] Vaccine) in Healthy Seronegative Women, 16 to 35 Years of Age","has_exemption":false,"start_date":"2018-04-30","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03469141","publication_url":"https://clinicaltrials.gov/study/NCT03469141","title":"Interactive Telehealth and Auto-Biofeedback Sensor System for Pressure Ulcer Prevention After SCI","has_exemption":false,"start_date":"2018-05-01","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Rancho Research Institute, Inc.","sponsor_slug":"rancho-research-institute-inc","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT04516148","publication_url":"https://clinicaltrials.gov/study/NCT04516148","title":"A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting","has_exemption":false,"start_date":"2018-05-29","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT05102877","publication_url":"https://clinicaltrials.gov/study/NCT05102877","title":"The Effect of Sensory Level Versus Motor Level Electrical Stimulation of Pharyngeal Muscles in Acute Stroke Patients With Dysphagia","has_exemption":false,"start_date":"2018-09-19","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Casa Colina Hospital and Centers for Healthcare","sponsor_slug":"casa-colina-hospital-and-centers-for-healthcare","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT03477006","publication_url":"https://clinicaltrials.gov/study/NCT03477006","title":"Pragmatic Prehospital Group O Whole Blood Early Resuscitation (PPOWER) Trial: A Prospective, Interventional,Randomized, 3 Year, Pilot Clinical Trial","has_exemption":false,"start_date":"2018-11-20","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"Jason Sperry","sponsor_slug":"jason-sperry","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03701074","publication_url":"https://clinicaltrials.gov/study/NCT03701074","title":"Single Center, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus","has_exemption":false,"start_date":"2018-12-15","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"University of South Alabama","sponsor_slug":"university-of-south-alabama","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03758924","publication_url":"https://clinicaltrials.gov/study/NCT03758924","title":"A Double-Blind, Randomized, Placebo-Controlled, Dose Titration Study of ANAVEX2-73 in Patients With Rett Syndrome","has_exemption":false,"start_date":"2019-02-28","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Anavex Life Sciences Corp.","sponsor_slug":"anavex-life-sciences-corp","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT03909607","publication_url":"https://clinicaltrials.gov/study/NCT03909607","title":"Comparison of Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute and Chronic Painful Conditions in the ED: A Prospective, Randomized Trial","has_exemption":false,"start_date":"2019-04-16","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"Antonios Likourezos","sponsor_slug":"antonios-likourezos","status":"reported-late","is_pact":false,"days_late":159},{"registry_id":"NCT04060992","publication_url":"https://clinicaltrials.gov/study/NCT04060992","title":"Can Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist Withstand When Administered at Different Points in the Menstrual Cycle?","has_exemption":false,"start_date":"2019-10-01","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT04065919","publication_url":"https://clinicaltrials.gov/study/NCT04065919","title":"Evaluation of Liposomal Bupivacaine Compared to Usual Care and Its Effects on Pain for Cardiac Surgery","has_exemption":false,"start_date":"2019-10-01","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Florida Heart and Lung Institute","sponsor_slug":"florida-heart-and-lung-institute","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT04094870","publication_url":"https://clinicaltrials.gov/study/NCT04094870","title":"Z 31801 - A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women","has_exemption":false,"start_date":"2019-10-30","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04103021","publication_url":"https://clinicaltrials.gov/study/NCT04103021","title":"Effectiveness of Ultrasound Guidance for Port-A-Cath Insertion in Cancer Patients","has_exemption":false,"start_date":"2019-10-30","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"Omar Mokhtar Hussein","sponsor_slug":"omar-mokhtar-hussein","status":"overdue","is_pact":false,"days_late":1643},{"registry_id":"NCT04165031","publication_url":"https://clinicaltrials.gov/study/NCT04165031","title":"A Phase 1/2 Study of LY3499446 Administered to Patients With Advanced Solid Tumors With KRAS G12C Mutation","has_exemption":false,"start_date":"2019-11-28","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04322812","publication_url":"https://clinicaltrials.gov/study/NCT04322812","title":"Evaluation of the Effects of Photobiomodulation Therapy (PBMT) Combined With Static Magnetic Field (sMF) on Temporary Pain Relief in Fibromyalgia Patients: a Randomized Placebo-controlled Trial","has_exemption":false,"start_date":"2020-03-31","completion_date":"2020-10-30","has_results":false,"results_due":true,"sponsor_name":"University of Nove de Julho","sponsor_slug":"university-of-nove-de-julho","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04812184","publication_url":"https://clinicaltrials.gov/study/NCT04812184","title":"Adhesive Tape Placement on Patients' Masks in the Emergency Department Increases Compliance of Proper Face Mask Use","has_exemption":false,"start_date":"2020-04-01","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":false,"days_late":10},{"registry_id":"NCT04500821","publication_url":"https://clinicaltrials.gov/study/NCT04500821","title":"Evaluation of the LipiFlow System With a New Activator (Model LFD-2100)","has_exemption":false,"start_date":"2020-10-02","completion_date":"2020-10-30","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Surgical Vision, Inc.","sponsor_slug":"johnson-johnson-surgical-vision-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01742117","publication_url":"https://clinicaltrials.gov/study/NCT01742117","title":"Tailored Antiplatelet Initiation to Lesson Outcomes Due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention (TAILOR-PCI)","has_exemption":false,"start_date":"2013-05-31","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01831024","publication_url":"https://clinicaltrials.gov/study/NCT01831024","title":"Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer","has_exemption":false,"start_date":"2013-07-31","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"Target Health Inc.","sponsor_slug":"target-health-inc","status":"overdue","is_pact":true,"days_late":1642},{"registry_id":"NCT02188121","publication_url":"https://clinicaltrials.gov/study/NCT02188121","title":"Fixed Dose Intervention Trial of New England Enhancing Survival in Serious Mental Illness Patients","has_exemption":false,"start_date":"2015-02-28","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"reported-late","is_pact":true,"days_late":360},{"registry_id":"NCT03141970","publication_url":"https://clinicaltrials.gov/study/NCT03141970","title":"Randomized, Multicentric, Open Label, Parallel Group Trial to Compare the Efficacy of 6-months Versus 3-months Therapy With Prednisolone for the First Episode of Idiopathic Nephrotic Syndrome in Children Younger Than 4 Years","has_exemption":false,"start_date":"2015-07-01","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"All India Institute of Medical Sciences","sponsor_slug":"all-india-institute-of-medical-sciences","status":"overdue","is_pact":true,"days_late":1642},{"registry_id":"NCT02339740","publication_url":"https://clinicaltrials.gov/study/NCT02339740","title":"A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid","has_exemption":false,"start_date":"2015-07-21","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"reported-late","is_pact":true,"days_late":17},{"registry_id":"NCT02366728","publication_url":"https://clinicaltrials.gov/study/NCT02366728","title":"Evaluation of Overcoming Limited Migration and Enhancing Cytomegalovirus-specific Dendritic Cell Vaccines With Adjuvant TEtanus Pre-conditioning in Patients With Newly-diagnosed Glioblastoma","has_exemption":false,"start_date":"2015-10-12","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","sponsor_slug":"mustafa-khasraw-mbchb-md-frcp-fracp","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02807779","publication_url":"https://clinicaltrials.gov/study/NCT02807779","title":"Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging","has_exemption":false,"start_date":"2016-02-10","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported-late","is_pact":true,"days_late":470},{"registry_id":"NCT02685709","publication_url":"https://clinicaltrials.gov/study/NCT02685709","title":"A Phase 3, Randomized, Active Controlled Study to Evaluate Maintenance of Response, Safety and Patient Reported Outcomes in Acromegaly Patients Treated With Octreotide Capsules vs. Parenteral Somatostatin Receptor Ligands","has_exemption":false,"start_date":"2016-02-29","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"Chiasma, Inc.","sponsor_slug":"chiasma-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02680535","publication_url":"https://clinicaltrials.gov/study/NCT02680535","title":"A Study of MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue","has_exemption":false,"start_date":"2016-02-29","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"Nanospectra Biosciences, Inc.","sponsor_slug":"nanospectra-biosciences-inc","status":"overdue","is_pact":true,"days_late":1642},{"registry_id":"NCT02499497","publication_url":"https://clinicaltrials.gov/study/NCT02499497","title":"A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer","has_exemption":false,"start_date":"2016-02-29","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02785250","publication_url":"https://clinicaltrials.gov/study/NCT02785250","title":"A Phase 1b/2 Study of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide and Epacadostat (INCB024360) in Patients With Recurrent Ovarian Cancer","has_exemption":false,"start_date":"2016-04-30","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"ImmunoVaccine Technologies, Inc. (IMV Inc.)","sponsor_slug":"immunovaccine-technologies-inc-imv-inc","status":"reported-late","is_pact":true,"days_late":680},{"registry_id":"NCT02930889","publication_url":"https://clinicaltrials.gov/study/NCT02930889","title":"Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)","has_exemption":false,"start_date":"2016-10-01","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02688608","publication_url":"https://clinicaltrials.gov/study/NCT02688608","title":"Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/ Undifferentiated Thyroid Cancer","has_exemption":false,"start_date":"2016-10-31","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"Saad A Khan","sponsor_slug":"saad-a-khan","status":"reported-late","is_pact":true,"days_late":38},{"registry_id":"NCT02951104","publication_url":"https://clinicaltrials.gov/study/NCT02951104","title":"Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension","has_exemption":false,"start_date":"2016-11-30","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"Santa Barbara Cottage Hospital","sponsor_slug":"santa-barbara-cottage-hospital","status":"overdue","is_pact":true,"days_late":1642},{"registry_id":"NCT02733614","publication_url":"https://clinicaltrials.gov/study/NCT02733614","title":"A Proof of Concept (POC) Clinical Trial for Post-Traumatic Stress Disorder (PTSD) With a First-In-Class Vasopressin 1a Receptor Antagonist (SRX246)","has_exemption":false,"start_date":"2016-12-31","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"Azevan Pharmaceuticals","sponsor_slug":"azevan-pharmaceuticals","status":"reported-late","is_pact":true,"days_late":17},{"registry_id":"NCT04552054","publication_url":"https://clinicaltrials.gov/study/NCT04552054","title":"Preoperative Mixed Reality Technique Combined With Three-Dimensional Printing Navigational Template Guided Localizing Pulmonary Small Nodules : a Prospective, Unicenter, Randomized Study.","has_exemption":false,"start_date":"2018-05-01","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"Wen-zhao ZHONG","sponsor_slug":"wen-zhao-zhong","status":"overdue","is_pact":false,"days_late":1642},{"registry_id":"NCT03702686","publication_url":"https://clinicaltrials.gov/study/NCT03702686","title":"Pilot Study of the FEEDBACK System for Use With Infants in the Neonatal Intensive Care Unit (NICU) at the University of Virginia (UVA)","has_exemption":false,"start_date":"2018-10-03","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"Molex Ventures LLC","sponsor_slug":"molex-ventures-llc","status":"overdue","is_pact":false,"days_late":1642},{"registry_id":"NCT03597620","publication_url":"https://clinicaltrials.gov/study/NCT03597620","title":"An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis","has_exemption":false,"start_date":"2018-11-07","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"reported-late","is_pact":false,"days_late":65},{"registry_id":"NCT03883906","publication_url":"https://clinicaltrials.gov/study/NCT03883906","title":"Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant","has_exemption":false,"start_date":"2019-03-16","completion_date":"2020-10-31","has_results":true,"results_due":true,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03853980","publication_url":"https://clinicaltrials.gov/study/NCT03853980","title":"The INFORM Study: A Multi-Center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring With an Optimized Post-Procedure Treatment Plan","has_exemption":false,"start_date":"2019-03-18","completion_date":"2020-10-31","has_results":false,"results_due":true,"sponsor_name":"Recros Medica, Inc.","sponsor_slug":"recros-medica-inc","status":"overdue","is_pact":false,"days_late":1642}]}